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Excess of plasma free fatty acids (FFA) are highly associated with insulin resistance and 
are a major risk factor for the development of type 2 diabetes mellitus. This thesis 
investigates the effect of rosemary extract and rosemary extract polyphenols carnosic acid 
(CA), rosmarinic acid (RA) and carnosol (COH) on recovering/blunting FFA-induced 
insulin resistance in skeletal muscle cells and the mechanism(s) involved. Exposure of L6 
myotubes with the FFA palmitate significantly reduced the insulin-stimulated glucose 
uptake. Most importantly, the insulin-stimulated glucose uptake was restored in the 
presence of RE and its polyphenols CA, RA and COH. Furthermore, treatment with 
palmitate increased serine phosphorylation of IRS-1 and significantly decreased the 
insulin-stimulated phosphorylation of Akt. These effects were completely abolished in 
the presence of rosemary extract. Additionally, we investigated the effect of palmitate 
and rosemary extract on the phosphorylation and of JNK, mTOR, P70S6K and AMPK 
kinases. Our results indicate that palmitate treatment increased the phosphorylation of 
JNK, mTOR, p70S6K whereas rosemary extract completely abolished this effect. 
Additionally, rosemary extract increased the phosphorylation of AMPK even in the 
presence of palmitate. The expression levels of these proteins were not affected by any of 
the treatments. These results indicate that treatment with rosemary extract attenuated the 
palmitate-induced phosphorylation of the serine residues of IRS-1, mTOR, p70 S6K and 
JNK while increasing the phosphorylation of AMPK. Additionally, treatment with RE 
restored the insulin-stimulated glucose uptake in palmitate-induced insulin resistant cells.  
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CHAPTER1: BACKGROUND INFORMATION 




Insulin is a pleiotropic protein hormone mainly involved in maintaining glucose 
homeostasis and lowering postprandial glucose elevations by endorsing fat and skeletal 
muscle tissue glucose uptake from the circulation in addition to inhibiting endogenous 
glucose production (EGP) by the liver (1) (Figure 1). It was first discovered by Banting 
and Best in 1922 at the University of Toronto, Canada (2). Insulin is produced by the 
pancreatic β-cells in the islets of Langerhans. The half-life of insulin is around 5 minutes 
and is cleared by receptor-mediated endocytosis and degraded by lysosomal insulinase. 
After insulin is secreted and delivered to its target tissues, it binds its receptors located in 
the plasma membrane leading to activation of signaling cascades that result in the 
hormone’s effect.  
1.1.2 Role of insulin in glucose homeostasis 
 
Insulin plays a critical role in maintaining blood glucose homeostasis (Figure 1). 
After meal ingestion, there is a rise in blood glucose. This increase in blood glucose is 
sensed by the β cells of the islets of Langerhans in the pancreas and leads to insulin 
secretion into the blood circulation. Circulating insulin then binds to its receptors located 
on the plasma membrane of insulin target tissues such as skeletal muscle, adipose and 
hepatic tissue restoring physiologically normal levels of blood glucose (euglycemia). In 
skeletal muscle and adipose tissue, insulin promotes transport and utilization of glucose 
as well as storage in the form of glycogen and triglycerides respectively (3,4). On the 
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other hand, in the liver, insulin inhibits endogenous glucose production by inhibiting 
gluconeogenesis and glycogenolysis (Figure 1). The end result of the insulin actions is to 
maintain and restore plasma glucose levels within a physiological range of 4-7 millimolar 
(mM). 
 
Figure 1: The effect of insulin on its target tissues to regulate blood glucose 
homeostasis  
1.1.3 Insulin signaling cascade 
 
Insulin action is initiated by insulin binding to its receptor leading to an increase 
in the receptor’s tyrosine kinase activity towards intracellular substrates. When insulin 
binds to the  subunit of the receptor, it causes a conformational change allowing for 
autophosphorylation of the  subunit leading to an increase in the intrinsic tyrosine kinase 
activity domain of the receptor. The activation of the insulin receptor leads to 
phosphorylation of numerous intracellular substrates on tyrosine residues which includes 
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members of the insulin receptor substrate family (IRS) (Figure 2). Furthermore, the p85 
regulatory subunit of phosphatidylinositol-4,5-bisphosphate-3-kinase (PI3K) binds to 
tyrosine phosphorylated residues of IRS resulting in increased activity of its catalytic 
subunit p110. Activation of PI3K leads to generation of lipid phosphatidylinositol 3,4,5-
triphosphate (PIP3) from phosphatidylinositol 4,5-diphosphate (PIP2). Increased levels of 
PIP3 bind to phosphatidylinositol-3,4,5-phosphate-dependent kinase-1 (PDK-1) and 
protein kinase B (PKB/Akt) (5). PKB/Akt and PDK-1 proximate to the cell plasma 
membrane allowing phosphorylation of PKB/Akt on threonine308 by PDK-1 (5). 
Glucose uptake, glycolysis, glycogen/ protein synthesis and other insulin actions are 
mediated by PKB/Akt (6,7). The established substrates of PKB/Akt include a) glycogen 
synthase kinase-3; b) the Rab GTPase activating protein AS160/TBC1D4 involved in 
glucose transport and glucose transporters (GLUT) translocation to the cell membrane. c) 
Rheb GTPase activating tumor suppressor complex (1/2) (TSC1/2) involved in protein 
synthesis and a regulator of mammalian target of rapamycin (mTOR); d) Transcription 
factors Forkhead box protein (FoxO) mainly involved in the regulation of gluconeogenic 
genes (8,9). Insulin-stimulated phosphorylation of Akt leads to downstream 
phosphorylation of its substrate AS160 which causes inhibition of its Rab-GTPase 
activating protein (Rab-GAP) activity and has been established as a key component 
necessary for the GLUT4 translocation from an intracellular compartment to the plasma 
membrane (9,10) (Figure 2). Therefore, exposure of muscle and adipocytes to insulin 
leads to dramatic increase in GLUT4 translocation from the intracellular vesicles to the 
cell membrane via exocytosis and reducing GLUT4 internalization. The end result of this 
process is GLUT4 translocation to the cell membrane providing a route for glucose entry 
Inhibition of Free fatty acid-Induced Insulin Resistance by Rosemary Extract 
4 
 
down the concentration gradient via facilitated diffusion. Once transported inside the cell, 
glucose is converted to glucose-6-phosphate by the action of hexokinase following 
isomerization of glucose-6-phosphate to glucose-1-phosphate and activation to uridine-5-
diphosphate glucose which is later turned into glycogen by glycogen synthase. Insulin 
mediates glycogen deposition by synchronized transport of glucose and glycogen 
synthesis. Insulin leads to glycogen synthase activation in liver by dephosphorylation 
through inhibition of kinases including protein kinase A (PKA) and glycogen synthase 
kinase 3 (GSK3) and activation of protein phosphatase 1 (PP1) (11).  
 
Figure 2: Insulin signaling pathway leading to translocation of GLUT4 to the 
plasma membrane in skeletal muscle 
 




1.1.4 Insulin receptor 
 
 The binding of insulin to its receptor leads to activation of multiple intracellular 
molecules/ proteins that communicate the signaling downstream within the cell and lead 
to an induction of insulin-stimulated response. The insulin receptor has an intrinsic 
tyrosine kinase activity belonging to a large family of cell surface receptors called 
tyrosine kinases which also includes the insulin-like growth factor receptors (IGFR) (12). 
The structure of insulin receptor comprises of two extracellular subunits which contain 
the insulin binding domain and two transmembrane  subunits each including: an 
extracellular, a transmembrane and a cytosolic domain (13) (Figure 2). The cytosolic 
domain contains an ATP binding consensus sequence along with three clusters of 
tyrosine residues that may be phosphorylated as a result of insulin signalling (13). The 
tyrosine residue clusters are found a) proximal to the cell surface in the juxtamembrane 
domain, b) in the catalytic region which is located in the centre of the subunit and c) in 
the COOH-tail region (12). Insulin binding to the subunit of the receptor causes a 
conformational change of the receptor, resulting in autophosphorylation of the subunit 
tyrosine residues, leading to increases in the tyrosine kinase activity (12). A total of 13 
tyrosine residues have been identified in the  subunit with Y953, Y960, and Y972 being 
the key residues in the juxtamembrane region, Y1146, Y1151, and Y1152 in the catalytic 
domain, and Y1316, and Y1322 in the COOH-terminal domain. The catalytic domain 
corresponds to approximately 50% of the receptor’s autophosphorylation activity, 30-
35% of the activity corresponds to the COOH-terminal domain and 15% corresponds to 
the juxtamembrane domain (13). Studies have indicated that upon point mutation of 
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substitution of the tyrosine residues, located in different domains, with phenylalanine the 
insulin stimulated action is inhibited (13,14). Additionally, removal of the tyrosine 
residues (1146, 1151 and 1152) that lie on the catalytic subunit resulted in complete 
abolishment of the insulin-stimulated effects (13). 
1.1.5 Insulin receptor substrate  
 
The insulin receptor substrate (IRS) is a family of proteins consisting of at least 
four isoforms (IRS-1 to -4) (15). The expression of IRS-1 (180kDa) is mostly in adipose 
and skeletal muscle tissue and is involved in regulation of metabolic processes such as 
protein synthesis and glucose transport. IRS-2 (185 kDa) is mainly expressed in the liver, 
skeletal muscle and adipose tissue. IRS-3 is expressed in adipose and IRS-4 in 
neuroendocrine tissue and is suggested to be predominantly exerting negative regulation 
of the IRS-1 and IRS-2 (15). Appropriate IRS-1 signaling is crucial for insulin action and 
any disturbances in the IRS-1 expression could severely impair the insulin effects in its 
target tissues. Overexpression of IRS-1 in L6 skeletal rat muscle cells significantly 
increase basal and insulin-induced glucose uptake and increase the GLUT4 trafficking to 
the cellular membrane indicating that IRS-1 plays a major part in the insulin signaling 
pathway (16). Additionally, insulin-induced PI3K activity associated with IRS-1 was 
increased in these cells compared to control. On the other hand, silencing the IRS-1 gene 
using small interfering RNA (siRNA) showed significant reduction in insulin-stimulated 
glucose uptake and GLUT4 translocation in L6 muscle cells (16). In addition, knockdown 
of the IRS-1/2 gene in mice has led to the development of insulin resistance and T2DM 
indicating that IRS plays a crucial role in the insulin signaling in vivo (17,18). In primary 
skeletal muscle cells isolated from prediabetic patients (patients with an impaired insulin 
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tolerance) the insulin-stimulated glucose uptake was reduced by 30-50% compared to the 
healthy control and this reduction was associated with lower phosphorylation of IRS-2, 
reduced downstream signaling and activation of PI3K in response to insulin (19). In 
another study, skeletal muscle biopsies obtained from T2DM patients showed no 
reduction in protein expression levels of the IRS-1 or p85 subunit of PI3K, however they 
displayed significant reduction in the insulin-induced tyrosine phosphorylation of IRS-1 
and its downstream effector PI3K (20). Furthermore, significant reduction of insulin-
stimulated IRS-1 phosphorylation and PI3K activity along with a decrease of 2-
deoxyglucose uptake (53% compared to control) was seen in intact muscle strips from 
obese patients (21). Another study found that in skeletal muscle from lean type 2 diabetic 
subjects the insulin-stimulated IRS-1 phosphorylation and PI3K activation was 
significantly reduced in comparison to healthy individuals (22). It is important to note 
that the total IRS-1 protein levels were not reduced and were similar between all the 
groups (22). In normoglycemic subjects having a family history of type 2 diabetes, 
examination of skeletal muscle revealed insulin resistance that was associated with lower 
insulin-stimulated IRS-1 tyrosine phosphorylation and reduced IRS-1 associated PI3K 
activity (23). The current evidence indicate that significantly lower IRS tyrosine 
phosphorylation and IRS associated PI3K activity, resulting in decreased insulin-
stimulated glucose uptake in skeletal muscle. 
1.1.6 Importance of Phosphatidylinositiol-3-kinase in Insulin Signaling 
 
Phosphatidylinositol-3-kinase (PI3K) consists of a p110 catalytic subunit and a 
p85 regulatory subunit that has two SH2 domains which interact with specific 
phosphotyrosine-containing motifs, pYMXM and pYXXM, in the IRS proteins (5,6). The 
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PI3K family entails 14 members that are divided into four classes. Class I, II, and III 
belong to the lipid kinases group and class IV are related protein kinases (5). It should be 
noted that only class I family of heterodimeric p85/p110 PI3K are responsive to insulin 
(3). There are a few isoforms of p85 regulatory subunit such as p85α, p55α, p85β, and 
p55γ. Treatment of 3T3-L1 adipocytes with LY294002 (inhibitor of PI3K) completely 
inhibited GLUT4 translocation to the plasma membrane and blocked insulin-induced 
glucose uptake (24). Another study investigated the effect of wortmannin, another 
inhibitor of PI3K, and found that it completely abolished insulin-stimulated PI3K 
activation and glucose uptake in rat adipocytes (25). Inhibition of PI3K activity either by 
LY294002 or wortmannin blocks insulin-stimulated glucose uptake in skeletal muscle 
cells indicating that PI3K plays a crucial role in the action of insulin (26). Overexpressing 
of p110α led to 1.4 fold increase of basal glucose transport in comparison to the control 
group and increased translocation of GLUT4 in 3T3-L1 adipocytes (27). These studies 
clearly indicate that the PI3K and particularly p110 catalytic subunit is critical for 
GLUT4 translocation in vitro. A study investigating mice with heterozygous loss of 
p110α +/- p110β+/- showed 40% reduction in insulin-induced IRS-1 associated PI3K 
activity along with 50% decrease in PI3K activity and showed hyperinsulinemia and mild 
glucose intolerance compared to control (28). Furthermore, mice lacking p85α and p85β 
regulatory subunits of PI3K showed impaired PI3K signaling in muscle, insulin 
resistance and glucose intolerance (29). On the other hand, skeletal muscle cells obtained 
from T2DM subjects showed decreased IRS-1 tyrosine phosphorylation, decreased 
association of PI3K with IRS-1 and PI3K activity in response to insulin in comparison to 
skeletal muscle cells obtained from healthy individuals (30). The above mentioned in 
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vitro and in vivo studies provide evidence of the importance of PI3K in basal and insulin-
stimulated glucose uptake. 
1.1.7 Importance of Protein Kinase B (Akt /PKB) in Insulin Signaling  
 
Protein Kinase B (PKB/Akt) is a serine/threonine kinase which includes the three 
mammalian isoforms Akt1, Akt2, and Akt3. Akt1 is universally expressed in mammalian 
tissues while Akt2 is widely expressed in insulin target tissues including skeletal muscle, 
adipose and liver tissue. Akt3 is expressed in low levels in mammalian tissue excluding 
testes and brain. In order for Akt to be activated, phosphorylation of the threonine 
(Thr308) and serine residue (Ser473) is required (5). Inactivated Akt is mostly located in 
the cytoplasm however upon PI3K activation, Akt translocate to the cell membrane where 
it is phosphorylated by PDK resulting in its activation. In the absence of insulin, 
constitutively active Akt stimulated glucose uptake and GLUT4 translocation in 3T3-L1 
adipocytes (31). Similarly, constitutively active Akt1 increased glucose uptake in 3T3-L1 
GLUT4 overexpressing adipocytes and Chinese hamster ovary cells (32). Additionally, 
the study showed that inhibition of Akt using small interference RNA (siRNA) 
significantly lowered insulin-induced glucose uptake (32). In another study performed in 
Akt2-null adipocytes derived from immortalized mouse embryo fibroblasts (MEFs) the 
insulin-induced glucose uptake along with GLUT4 translocation were markedly 
decreased (33). Additionally, when Akt2 action was restored via re-expression the effect 
was reversed (33). Other studies found similar effect in muscle cells indicating 
abolishment of insulin-induced glucose uptake as a result to impaired Akt action 
(34,6,35). Mice that underwent homozygous deletion of Akt2 showed fasting 
hyperglycemia and impairment in the insulin-induced glucose uptake in muscle tissue in 
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vitro (36). Similarly, impaired insulin action in addition to hyperglycemia was observed 
in Akt2-null mice (37). Furthermore, decrease in insulin-induced glucose uptake (60%) 
and phosphorylation and activation of Akt was observed in adipocytes that were isolated 
from T2DM in comparison to adipocytes from healthy controls (38). Therefore, from the 
above mentioned studies it can be noted that Akt plays a critical role in insulin-stimulated 
GLUT4 trafficking to the cell membrane and loss of Akt function leads to insulin 
resistance and T2DM. From the in vitro and in vivo studies present in the literature it is 
already established that IRS, PI3K and Akt are important proteins involved in the action 
of insulin and glucose homeostasis and altering the levels of these protein in different 
experimental models has a serious impact on the insulin-induced glucose uptake. 
1.1.8 Importance of AS160 in Insulin Signaling 
 
The Akt substrate of 160kDa originally known as TBC1 domain family member 4 
(TBC1D4) is a protein containing a Rab-GAP (GTPase-activating protein) domain 
located at the COOH terminus and two phosphotyrosine-binding (PTB) domains located 
at the NH2 terminus (39). The presence of a Rab-GAP domain formed a hypothesis that 
Akt-mediated phosphorylation of AS160 may be involved in the regulation of GLUT4 
trafficking to the plasma membrane through the GAP activity towards Rab proteins. 
Therefore, it was suggested that Rab-GAP activity of AS160 endorses hydrolysis of GTP 
to GDP of Rab located on the GLUT4 storage vesicle (GSV) and that the GSV-bound 
Rabs in their inactive GDP-bound form are unable to undergo GLUT4 translocation. 
Upon AS160 phosphorylation by insulin, there is inactivation of the Rab-GTPase activity 
therefore the GSV-associated Rabs would become loaded with GTP which promotes the 
GLUT4 release and translocation to the plasma membrane (10). This hypothesis has been 
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tested in 3T3-L1 adipocytes where the phosphorylation sites of AS160 (Ser318, Ser588, 
Thr642, Ser751) were mutated to alanine (AS160-4P) and were coexpressed with 
GLUT4. The AS160-4P significantly reduced the insulin-stimulated GLUT4 
translocation to the cell membrane by 80% in comparison to the control (wild type) (40). 
This may suggest that the GAP activity in AS160-4P is unrestrained and cannot be 
attenuated by insulin-stimulated phosphorylation which would keep the GLUT4 vesicle 
Rab in its inactive GDP form thus preventing GLUT4 translocation to the cell membrane. 
In addition, the AS160-4P-induced effect is dependent on an intact Rab-GAP domain. 
Mutation of the putative GAP domain in AS160-4P (arginine 973 residue to lysine) 
abolished the inhibitory effect on GLUT4 translocation (40). Similarly, the insulin 
stimulated translocation of GLUT4 was inhibited by expression of the AS160-4P mutant 
in L6 muscle cells (41). A study found that insulin stimulation leads to AS160 
phosphorylation in isolated rat epitrochlearis skeletal muscle in a PI3K-sensitive manner 
(42). Moreover, other stimuli that were previously found to induce GLUT4 translocation 
including contraction and AICAR, stimulated AS160 phosphorylation (42) which 
indicates that AS160 is not a substrate for Akt alone but also for other kinases such as 
AMP-activated protein kinase (AMPK). Furthermore, in tibialis anterior muscle from 
mice overexpressing AS160-4P mutant, the insulin-stimulated glucose uptake was 
reduced by 30% compared to the vector expression control. Additionally, the contraction-
induced glucose uptake was reduced by 40%. This inhibitory effect of the AS160-4P was 
abolished in response to insulin and contraction when Arg973 was replaced with Lys in 
muscle (41). Taken together these studies provide evidence of the importance of the 
downstream substrate of Akt (AS160) in the insulin-stimulated glucose uptake. 
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1.2 Insulin Resistance  
 
Insulin resistance is a state in which there is a diminished responsiveness to 
normal circulating levels of insulin in the major insulin target tissues such as skeletal 
muscle, adipose and hepatic. Normal circulating levels of insulin in human plasma 
between meals range from 57–79 pmol/L (43). Alternatively, it can be defined as a failure 
of insulin target tissues to appropriately respond to normal physiological levels of insulin 
present in the blood. The state of insulin resistance is associated with elevated circulating 
free-fatty acids, obesity, inactive (sedentary) lifestyle, aging and genetic predisposition 
(5). Studies showed that the earliest metabolic defect in T2DM is impaired glycogen 
synthesis in muscle tissue as a consequence to reduced glycogen synthase activity 
(44,45). In an insulin resistant state, insulin-induced glucose uptake, utilization and 
storage of glucose as muscle glycogen is compromised (5,6). In adipose tissue insulin 
action to promote glucose uptake and storage as triglycerides as well as inhibiting 
hormone sensitive lipase (HSL) in order to supress lipolysis is compromised (46). 
Additionally, inhibition of liver gluconeogenesis and glycogenolysis in insulin resistant 
state is also compromised (46). As a consequence to skeletal muscle, adipose and liver 
tissue insulin resistance there is a chronic elevation of blood plasma glucose levels 
resulting in hyperglycemia. The side effect of chronically elevated glucose in the blood 
(hyperglycemia) may lead to short-term effects such as diabetic ketoacidosis, a metabolic 
state caused by breakdown of fatty acids in order to create energy thereby creating ketone 
bodies that significantly impair the blood buffering system or long-term effects such as 
cardiovascular damage that could lead to the development of cardiovascular disease, 
macrovascular/microvascular damage, nephropathy, neuropathy and retinopathy and 
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severe complications including infections and amputations (35,47). The pathophysiology 
of the above-mentioned conditions is complex and the exact etiology is often difficult to 
identify. However, people affected by diabetes are frequently affected by high levels of 
inflammation, oxidative stress and dyslipidemia that can result in cellular damage, 
atherosclerosis, high blood pressure and other conditions that lead to damaging the 
vasculature and other vital organs (35,47). Additionally, it should be noted that chronic 
hyperglycemia aggravates target tissue insulin resistance and it is a major contributor to 
pancreatic β cell exhaustion and loss of function.  
1.2.1 Muscle Insulin Resistance 
 
Skeletal muscle accounts for 75% to 80% of postprandial glucose uptake and is 
quantitatively the most important tissue involved in maintaining glucose homeostasis (3). 
As a result, skeletal muscle insulin resistance is a major contributor to imbalances in the 
blood glucose levels which will lead to hyperglycemia, decreased glucose tolerance and 
T2DM. Studies have confirmed that individuals suffering from T2DM are severely 
insulin resistant compared to weight-, age- and sex-matched controls (48). Additionally, 
as result to muscle insulin resistance there is an impairment in 85-90% of the total body 
glucose disposal (48). Evidence has shown that skeletal muscle insulin resistance 
precedes hepatic insulin resistance and insulin deficiency from dysfunctional pancreatic 
-islet cells by decades. 75-80% of insulin-induced glucose clearance is converted to 
glycogen in the muscle cells and the rest 25-20% is converted to carbon dioxide and 
water (49). In the case of muscle insulin resistance, recent evidence has indicated that 
impairment in the insulin-induced glucose transport is the main contributor to decreased 
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glycogen content and decrease in the phosphorylation activity contributes in much 
smaller extent (50). 
There are several mechanisms in which insulin-stimulated glucose uptake may be 
decreased including reduced expression of the insulin receptor, decreased tyrosine 
phosphorylation of the insulin receptor or IRS-1 as a result to reduced tyrosine kinase 
activity of the receptor, diminished downstream activation/phosphorylation of Akt and 
GLUT4 translocation to the cell membrane (51). Studies have shown, that serine 
phosphorylation of IRS-1 leads to impairment in the insulin signaling pathway which in 
turns leads to significant decrease in insulin-stimulated glucose uptake (52–54). Insulin 
resistance is strongly associated with obesity which is a major risk factor for the 
development of type 2 diabetes, cardiovascular disease and metabolic syndrome (51). 
Insulin-stimulated glucose uptake in muscle has shown to be significantly reduced in 
obese individuals and patients with type 2 diabetes (51). Additionally, reduced expression 
and tyrosine phosphorylation levels of IRS-1 were found in 30% of high risk subjects for 
type 2 diabetes including obese subjects and first-degree relatives of type 2 diabetic 
individuals (55). Signaling molecules such as mTOR (56,57), p70 S6K (58,59), GSK3 
(60), c-Jun N-terminal kinase (JNK) (61) and PKC's (62) have been implicated to be 
involved in the serine phosphorylation of IRS-1 protein which leads to reduction in the 
insulin-stimulated glucose uptake in skeletal muscle and adipose tissue (51) (Figure 3). 
Multiple studies have found that elevated saturated free fatty acids (FFA) levels lead to 
insulin resistance by affecting the above mentioned molecules (56,59,61–64). The 
following section describes in detail the signaling molecules involved in insulin 
resistance.  






Figure 3: Proposed mechanism of FFA-induced insulin resistance in skeletal muscle 
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1.3 Mechanisms Underlying Insulin Resistance 
 
1.3.1 Serine phosphorylation of IRS-I and insulin resistance 
 
The involvement of the serine phosphorylation of IRS-1 in insulin resistance was 
first demonstrated a few decades ago when 17 okadaic acid was used in skeletal muscle 
cells and 3T3-L1 adipocytes. Okadaic acid significantly reduced insulin-stimulated 
GLUT4 translocation and glucose uptake by inhibiting tyrosine phosphorylation of IRS-1 
and its downstream effectors such as PI3K (64,65) (Table 1). The exact mechanism of the 
inhibition was not known at the time however it was later discovered that okadaic acid 
increases the Ser307 phosphorylation of IRS-1 (65,55). Moreover, prolonged exposure to 
insulin (hyperinsulinemia) has shown to increase serine phosphorylation of IRS-1 in 
skeletal muscle and adipocytes indicating that negative feedback mechanism may be 
involved in the uncoupling of IRS-1 protein from its upstream/downstream members and 
prevents normal functioning of the insulin signaling (66). 
The mechanism behind the serine phosphorylation of IRS-1 was also investigated 
in L6 muscle cells. Although these cells exhibit high basal serine phosphorylation of IRS-
1 in comparison to healthy human skeletal muscle (67), they are extensively used due to 
being the most feasible in vitro skeletal muscle model and having the ability to respond to 
insulin. The increased serine phosphorylation of IRS-1 is clearly correlated to reduced 
tyrosine phosphorylation leading to decreased glucose uptake (68). Numerous cytokines 
and protein kinases lead to an increased levels of serine phosphorylation of IRS-1 and at 
the same time diminish the insulin-stimulated phosphorylation of IRS-1 on its tyrosine 
residues. Hyperphosphorylation of the serine residues of IRS-1 makes a poor substrate for 
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the insulin receptor leading to inhibition of its downstream effects. For instance, 
diabetogenic agents may cause serine/threonine protein kinase activation or they may 
lead to inactivation of serine/threonine phosphatases which would lead to an increase of 
serine phosphorylation of IRS-1 and diminished insulin action (53) (Table 1). In different 
rodent models of obesity including rats and mice inhibiting seine phosphorylation of IRS-
1 led to improved tyrosine phosphorylation and insulin sensitivity. 
Phosphorylation of different serine residues located on IRS-1 has been correlated 
to decreased downstream effector activation such as PI3K association and Akt 
phosphorylation/activity and ultimately glucose uptake. The end of phospho The insulin 
resistance phenomenon remains complex tyrosine binding (PTB) domain contains Ser307 
which moderates the interaction of IRS-1 with the insulin receptor (69). The 
proinflammatory cytokine TNF-has been implicated in the development of insulin 
resistance therefore several studies have investigated the effect of TNF-on IRS-1 
phosphorylation. Increase in TNF-s linked to increase of Ser307 phosphorylation on 
IRS-1 in adipose, liver and muscle tissue (69,70,64,71). Additionally, stimuli such as 
increased levels of FFA are also implicated in serine phosphorylation of IRS-1. Increased 
levels of Ser307 phosphorylation were observed in mice fed with high fat diet (72). 
Additionally, a study found that decreased phosphorylation of Ser612 by mitogen 
activated protein kinase (MAPK) is associated to improved insulin-induced tyrosine 
phosphorylation of IRS-1 in mice (73). Similarly, HFD fed mice lacking 4E-BPs showed 
an increase Ser636/639 phosphorylation of IRS-1 (74). Ob/ob and K/KAy mice fed with 
HFD also exhibited increased phosphorylation of Ser307 and Ser636/639 (59). 
Furthermore, there was a hyperphosphorylation of the serine residues (632/639) of IRS-1 
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in hepatocytes treated with 0.4 mM palmitate for 22 hours (56). Moreover, increase of 
Ser1101 phosphorylation on IRS-1 decreased the insulin-stimulated tyrosine 
phosphorylation of IRS-1 and downstream effector proteins such as Akt in C2C12 muscle 
cells (75). The studies above indicate that exposure to FFA leads to phosphorylation of 
Ser307, Ser636/639 as well as Ser1101 on IRS-1 which is highly correlated with reduced 
insulin action and induction of insulin resistance (Table 1). 
Table 1: Kinases involved in different serine phosphorylation sites of IRS-1 





Tissue Effect on 
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Aguire et al. 
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Gual et al. 
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1.3.2 The Glycogen synthase kinase-3 (GSK3) pathway 
 
Glycogen synthase kinase-3 (GSK3) is a 51 kDa serine/threonine protein kinase 
predominantly involved in the regulation of glycogen synthesis by inactivating glycogen 
synthase. Additionally, GSK3 is also involved in the regulation of blood glucose 
homeostasis and is correlated with the development of insulin resistance (77).  
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GSK3 and GSK3 are the 2 isoforms expressing high levels of homology in 
regards to biological function and structure (78). The GSK3 isoforms have both an 
inhibitory serine phosphorylation site (Ser21 for GSK3and Ser9 for GSK3 and a 
catalytic tyrosine activation site (Y279 for , and Y216 for ) (77). GSK3 is nearly 
always active therefore Akt or other stimuli can cause serine phosphorylation of GSK3 
leading to inhibition of its activity (77). 
Correlation between type 2 diabetes and GSK3 has been reported in patients with 
type 2 diabetes and both isoforms were significantly elevated in skeletal muscle tissues of 
these subjects (77). Furthermore, GSK3 elevation in expression and activity levels was 
found to have an inverse relationship to insulin action in type 2 diabetes patients 
undergoing hyperinsulinemic/euglycemic clamp test (79). Studies conducted in 3T3-L1 
adipocytes have demonstrated that GSK3 activation leads to serine phosphorylation of 
IRS-1 which in turns attenuates insulin-induced tyrosine phosphorylation of IRS-1 (80). 
A study suggested that phosphorylation of the Ser332 on IRS-1 by GSK3 significantly 
attenuated insulin signaling in C2C12 muscle cells (81). Additionally, in muscle obtained 
from individuals that were classified as having metabolic syndrome, activation of GSK3 
was associated with an increased phosphorylation of Ser337 on IRS-1 (82).Moreover, it 
was indicated that Ser332 is a GSK3 site of phosphorylation and Ser336 acts as a 
“priming” site required for GSK3 action (81). In summary, GSK3 is one of the key 
regulators involved in glucose homeostasis and may be one of the players involved in the 
development of insulin resistance. 
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1.3.3 Insulin Resistance and c-Jun N-terrninal Kinase (JNK)  
 
JNK is a stress activated serine/ threonine kinase and a member of the MAPK 
family (83). JNK isoforms include JNKI (46kDa), JNK2 (54kDA), and JNK3 (54kDA). 
JNK1 and JNK2 are found to be commonly expressed in majority of tissues however 
JNK3 is mostly expressed in the brain, heart and testes (83). Stimulation of JNK1 is 
assumed to be involved in the pathology involving obesity and type 2 diabetes. 
Activation of JNK leads to the formation of a dimer and translocation to the nucleus 
where it causes phosphorylation of transcription factors such as c-Jun thereby mediating 
gene transcription (84). Phosphorylation of Thr183/Tyr185 residue of JNK is considered 
a site for activation (85). 
JNK may be activated by different environmental stressors including FFA, 
radiation, growth factors, cytokines like tumor necrosis factor alpha (TNF-) or 
interleukin-(IL- (3) (54). In vitro studies performed in HEK293T hepatocytes have 
shown that JNK1 and JNK2 have similar affinity and activity in regards to Ser307 
phosphorylation of IRS-1 (84). Existing evidence indicate that JNK may be a major 
mediator involved in the development of insulin resistance. The increase in JNK 
activation was associated with Ser307 phosphorylation of IRS-1 in skeletal muscle and 
liver (83). Studies showed that TNF-leads to stimulation of JNK which in turn causes 
phosphorylation of Ser307 residues on IRS-1 in adipose and liver and muscle 
(69,70,64,71). Mutation of Ser307 to alanine abolishes IRS-1 phosphorylation by JNK 
and attenuates the inhibitory effect of TNF-on IRS-1 (69). 
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In comparison to high saturated fat diet where insulin resistance was established 
and confirmed by a hyperinsulinemic-euglycemic clamp, JNK phosphorylation was not 
increased in normal diet fed controls rats in both muscle and liver tissue (83). A study has 
shown that JNK-interacting protein 1 (JIP1) responsible for binding of JNK signaling 
pathway components is needed for JNK activation and inhibition of IRS-1 in the adipose 
tissue of obese mice (86,55). Furthermore, in JIP-1 deficient mice insulin-induced 
tyrosine phosphorylation was increased and IRS-1 (Ser 307) was decreased in epidydimal 
fat pads (86,55). 
Moreover, continuous JNK activation was observed in primary pancreatic J3 cells 
and mouse hepatocytes from HFD fed and STZ-induced insulin resistant mice (87). 
Additionally, targeted mutation of the JNK1 locus in mice abolished JNK expression and 
showed to prevent HFD-induced insulin resistance (87). In agreement with the previous 
studies Solinas et al 2006 found that phosphorylation of the Ser307 residues on IRS-1 is 
the main mechanism involving JNK-mediated induction of insulin resistance in this study 
(70,87). In rodent in vivo models of obesity insulin sensitivity is significantly improved 
by inhibiting serine phosphorylation of IRS-1 together with improvement in the impaired 
tyrosine phosphorylation of IRS-1 in Jnk1-/- and Jnk2-/- C57BL/6J mice (61). 
Studies have also investigated the differences between the JNK1 and JNK2 
involvement in high-fat diet induced insulin resistance and obesity in vivo. Mice lacking 
JNK1 have significantly improved insulin sensitivity and exhibited protective effect 
against high fat-induced insulin resistance in liver. Mice lacking JNK2 on the other hand, 
did not have any effect on the insulin sensitivity. As a result, JNK2 was ruled out as a key 
mediator of establishing insulin resistance, type 2 diabetes and obesity (84). It is very 
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interesting to note that JNK2 and not JNK1 deficient mice exhibited protective effects 
against type 1 diabetes and atherosclerosis. As a result, it can be concluded that both 
isoforms may play a role in influencing the pathology of diabetes (84). JNK activation 
has been inhibited by rosiglitazone, an antidiabetic drug belonging to the family of 
thizolidinediones, leading to normalizing blood glucose levels in insulin resistant mice 
(88). Rosiglitazone given to high fat fed obese mice with an established insulin resistance 
significantly inhibited JNK activation and reduced insulin resistance (89).  
1.3.4 Protein Kinase C (PKC) and Insulin Resistance in Skeletal Muscle 
  
PKC is a large class of serine/threonine protein kinases consisting of 
approximately 10 different isoforms. PKC’s are involved in variety of cellular processes 
including cellular growth differentiation and cell signaling pathways (90,91). The PKC 
family is classified in 3 major subgroups including conventional PKC’s ( cPKC) referring 
to calcium and diacylglycerol-dependent PKC’s (PKC , I-II, and novel calcium-
independent PKC’s (nPKC) which includes PKCand and atypical PKC’s 
(aPKC) including PKC and.  
The insulin resistance phenomenon remains complex and there is evidence for 
PKC’s involvement. A study found that PKCwas involved in the Ser1101 
phosphorylation of IRS-1 in 3T3-L1 adipocytes and C2C12 skeletal muscle cells thus 
preventing the downstream effect of insulin and glucose uptake (62). Additionally, 
phosphorylation Ser1101 on IRS-1 was also increased though nutrient (amino acids 
infusion) and hormonal (insulin) stimulation of p706SK in obese mice (75). 
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Increase in muscle PKC activity in skeletal muscle seen in rats that underwent 
lipid infusion resulting in high circulating levels of FFA resulted in 50% decrease in IRS-
1 associated PI3K activity and insulin-stimulated IRS-1 tyrosine phosphorylation as well 
as increased muscle ser307 on IRS-1 (93). Additionally, PKC can activate IKK which in 
turn leads to Ser307 phosphorylation of IRS-1 (93). Moreover, lipid infusion in Wistar 
rats caused increase in PKCθ activity as a result to DAG accumulation (94). A study 
indicated that overexpression of dominant negative PKC in skeletal muscles leads to 
obesity and impairment of the IR/IRS-1/PI3K signaling cascade and its downstream 
effectors such as Akt which is implicated in insulin resistance (95). A serial muscle 
biopsies of lean, obese and obese-diabetic human subjects before and during lipid 
infusion showed that the total and cytosolic DAG accumulation was associated with 
PKCθ activation and impairment in insulin signaling (96). Similarly, a study by ltani et 
al. reported a three-fold increase in DAG accumulation that resulted in changes in 
PKCand PKC in lipid-induced insulin resistant human muscle (97) Furthermore, 
administration of lipid infusions in rats and humans stimulated activation of PKC and 
PKCleading to impairment of insulin-stimulated glucose uptake in skeletal muscle 
(98,99). Additionally, high levels of saturated free-fatty acid (palmitate) led to 5-fold 
increase in PKCn L6 skeletal muscle cells, while the PKC inhibitor Ro 31.8220 
attenuated the palmitate induced insulin resistance (100). An in-depth study on PKC in 
mice reported that muscle PKCincreased with age and its deletion improved insulin 
sensitivity (101). The above studies indicate the potential involvement of the PKC family 
of signaling molecules in the development of type 2 diabetes.  
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1.3.5 IKK-NFkB Pathway and Insulin Resistance in Skeletal Muscle 
 
The family of transcription factors NFkB are involved in the regulation of 
multitude of genes including the regulation of pro-inflammatory genes. The proteins of 
NFkB consist of five members including p50, p65, RelB and c-Rel. In order to initiate 
transcriptional modification in the cell, two protein members of NFkB are necessary to be 
dimerized and bind to DNA. The predominant activating dimer of NFkB in skeletal 
muscle is the p50-p65 heterodimer (63). Furthermore, NFkB is generally localized in the 
cytoplasm where it is associated with the inhibitory protein inhibitor of kappa B 
(IkBStimuli such as ROS, cytokines, hyperglycemia and FFA are found to activate IkB 
kinase (IKK), which is an upstream regulator of IkB. When, IKK becomes activated it 
leads to rapid IkB phosphorylation and dissociation from NFkB. This further leads to 
degradation of IkB by the proteasomes in the cytoplasm (63). The degradation of IkB 
allows NFkB to be liberated from its inhibitory activity, enters the nucleus and causes 
induction of transcription of genes.  
Exposure of L6 myotubes to palmitate significantly reduced insulin-stimulated 
glucose uptake and PI3K/Akt signaling while stimulated IkB degradation and NFkB 
translocation to the nucleus (52). Furthermore, the IKK inhibitors acetylsalicylate and 
parthenolide, abolished the palmitate-induced reduction in insulin-stimulated glucose 
uptake. Additionally, the decrease in insulin-stimulated glucose uptake seen with 
palmitate was attenuated in the presence of SN50, an inhibitor of NFkB translocation 
(52). Taken together these data indicate that the FFA-induced insulin resistance is 
prevented by inhibition of nuclear translocation of NFkB in L6 muscle cells (52). Muscle 
samples of vastus lateralis collected from T2DM patients indicated that there was a 60% 
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decrease in the IkB protein, an indication of elevated IKK/NFkB activity, which was 
correlated with muscle insulin resistance assessed with hyperinsulinemic-euglycemic 
clamp (63). Moreover, when T2DM subjects were exposed to aerobic exercise for 8 
weeks, the IkB protein levels and glucose uptake were increased by 50% and 37% 
respectively and the TNF- levels were decreased by 40% (63). Increase in TNF 
expression was linked to increase in IKK phosphorylation (63).  
A study reported that administration of salicylate (aspirin) in T2DM patients 
significantly decreased the plasma glucose levels (102). Salicylates are also reported to 
inhibit IKK activity and translocation of NFkB (103,104,102), suggesting that IKK may 
be a key player involved in the development of insulin resistance. Additionally, inhibition 
of IkBby salicylates prevented fat-induced pancreatic beta cell dysfuntion both in vitro 
and in rodents (in vivo). Overall, these findings indicate that the NFkB signaling pathway 
may be involved in the development of insulin resistance.  
1.3.6 mTOR and p70 S6K Pathway and Insulin Resistance in Skeletal Muscle 
 
The mammalian target of rapamycin (mTOR) is a 289 kDa serine/threonine 
kinase that is activated by hormonal factors such as insulin and nutritional factors such as 
amino acids (105,106). mTOR plays a major role in cellular growth and maintaining 
nutritional homeostasis. However, mTOR is often implicated in tumors where its activity 
is frequently increased (107). mTOR consists of two different complexes: a rapamycin-
sensitive complex which includes the regulatory-associated protein of mTOR known as 
raptor (TORC1) and rapamycin-resistant complex known as rictor (TORC2) (105,106). 
Akt and mTOR signaling comprises the tuberous sclerosis complex (TSC) consisting of 
TSC1, TSC2, and a member of Ras family Rheb-GTPase (105). Rheb possesses intrinsic 
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GTPase activity and has the ability to bind to both GDP and GTP. The activity of mTOR 
is increased when Rheb is bound to GTP (108). Following phosphorylation of Akt, TSC2 
gets phosphorylated and inhibited which drives the intrinsic GTPase activity of Rheb 
towards the GTP-bound /(active) form (108). Contrarywise, mTOR activity is supressed 
when Rheb is bound to GDP (105,108).  
Phosphorylation of mTOR may be on different serine residues in order for its 
activity to be increased. For instance, PI3K-Akt phosphorylation of mTOR is on the 
Ser448 residue leading to increased mTOR activity (107). In order for mTOR to be 
activated different subunits of TORC1 for instance proline-rich Akt substrate 40 
(PRAS40) are required for complete activation (108). A study has shown that PRAS40 is 
also required for activation of mTOR via Akt (109). and it is also reliant on the 
interaction of PRAS40 with mTOR on its kinase domain (109). Phosphorylation of the 
Ser2448 was reported to be an Akt phosphorylation site because it is sensitive to PI3K 
inhibition which leads to a decrease in the Akt activity (107,110). Phosphorylation of the 
Ser2448 residue of mTOR is widely accepted as an indicator of activation (107,110).  
One of the downstream effectors of mTOR is the serine/threonine kinase, mitogen 
activated p70 S6K at 70 kDa which regulates the translation of a class of mRNA 
transcripts containing an oligopyrimidine tract at the start of their transcriptional 
sequence (111). Several of the mechanisms involved in protein synthesis are encoded by 
this class of mRNA transcripts which are responsible for approximately 20% of the 
cellular mRNA (111). The above process is accomplished by activation/phosphorylation 
of p70 S6K and further phosphorylation of 40S ribosomal subunit protein S6 which leads 
to promotion in the mRNAs translation (111). The regulation of p70 S6K may be 
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dependent on mTOR activation. The TORC1 complex stimulates phosphorylation of p70 
S6K, therefore phosphorylation of the Thr229 in the catalytic domain and Thr389 in the 
linker domain are crucial for the action of p70 S6K (111). Moreover, phosphorylation of 
Thr389 mostly correlates with increased p70 S6K activity in vivo (112). 
A study has shown that mTOR and p70 S6K can be activated by increasing amino 
acid levels which leads to serine phosphorylation of IRS-1 which in turn leads to decrease 
in insulin action in 3T3-L1 adipocytes and L6 muscle cells (113). The activity of mTOR 
and p70S6K was also highly elevated in hepatic and skeletal muscle tissue of rats fed 
with high fat diet which indicates that both kinases may play in the development of 
insulin resistance in vivo (74). This effect was completely abolished when the mTOR 
inhibitor rapamycin was used. The inhibition of mTOR as a result to rapamycin stems 
from the ability of rapamycin to interfere with the FKBP-rapamycin binding pocket of 
TOR (107). Another study performed on insulin resistant 3T3-L1 adipocytes that were 
pretreated with rapamycin showed an increase in glucose uptake indicating that mTOR 
may be downregulating insulin signaling (114). Additionally, treatment with rapamycin 
reduced serine phosphorylation of IRS-1 while prolonging insulin-induced PI3K activity 
in mouse skeletal muscle cells (75). Another study found that the phosphorylation of 
mTOR was significantly increased in FFA palmitate treated hepatocytes (56).  
In addition to mTOR, its downstream effector p70 S6K is found to be implicated 
in the impairment of normal insulin signaling in both skeletal and adipose tissue (115). In 
vitro studies have demonstrated that treatment with small interference RNA against p70 
S6K markedly increased insulin-induced Akt phosphorylation and improved insulin 
sensitivity in MEF mouse embryonic fibroblast cells (116). Mice that underwent p70 S6K 
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gene deletion had lower Ser307 and Ser636/639 phosphorylation of IRS-1 and improved 
insulin sensitivity when fed with high fat diet in comparison to their controls (74). In 
addition, a study has found that p70 S6K-deficient mice are protected from obesity when 
treated with high fat diet (59). On the other hand, increased levels of p70 S6K has been 
associated with a reduced Akt activity in insulin-resistant obese rodents (59). Both mTOR 
and p70 S6K regulate glucose homeostasis by negative feedback mechanism. When 
glucose homeostasis is achieved, Ser307 and Ser636/639 phosphorylation of IRS-1 is 
activated in order to inhibit the insulin-induced glucose uptake and maintain homeostasis. 
However, chronic hyperstimulation of mTOR and p70 S6K may lead to insulin resistance 
in skeletal muscle, adipose tissue and liver. 
1.3.7 Free Fatty Acids (FFA)-Induced Skeletal Muscle Insulin Resistance  
Free Fatty acids (FFA) are non-esterified fatty acids (NEFA) that play a pivotal 
role in establishing insulin resistance and type 2 diabetes mellitus (64). Studies that used 
nuclear magnetic resonance (NMR) spectroscopy showed a strong association between an 
intramyocellular triglyceride accumulation with skeletal muscle insulin resistance 
(117,118). An explanation for this phenomenon may be obtained from the Randle 
hypothesis in which the free fatty acids compete with glucose for substrate oxidation 
(119). Philip Randle proposed the theory in which elevated FFA leads to increase of 
mitochondrial acetyl-CoA/CoA and NADH+/NAD+ ratios which ultimately lead to 
inhibition of the pyruvate dehydrogenase activity and increase in citrate levels which in 
turn hinders phosphofructokinase activity leading to decrease in glucose uptake (119). 
Moreover, studies found that skeletal muscle exposure to elevated FFA attenuates 
downstream insulin-induced Akt phosphorylation. Additionally, Akt inhibition has also 
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been associated with elevated ceramide concentration which is released as a result to 
acyl-CoA metabolism (64,120). Studies showed that exposure of rodent myotubes to 
palmitate increases the accumulation of ceramide which leads to insulin resistance 
(121,122). Pharmacological inhibition of ceramide synthesis using myriocin or triacsin-C 
prevented insulin resistance and restored glycemic control in prediabetic obese rats (123). 
An increase in ceramides in turn can often lead to activation phosphatases including 
phosphatase 2A and an increase in PKC activity that leads to dephosphorylation and 
inhibition of Akt thereby diminishing the insulin-induced glucose uptake in skeletal 
muscle (124,125).  
L6 skeletal muscle cells treated with 0.75mM for 16 hours of palmitate had 
markedly decreased GLUT4 translocation to the cell membrane associated with a 
decrease in glucose uptake (126). In addition, in vivo studies performed in Sprague-
Dawley rats infused with intralipid, showed a reduction in insulin sensitivity and a two 
fold increase in Ser307 phosphorylation of IRS-1 in muscle (127). Therefore, an increase 
in intramuscular and circulating FFA in overweight and obese individual may explain the 
reason for the increased risk of insulin resistance and type 2 diabetes development (51). 
Intramyocellular lipids do not seem to cause insulin resistance because they are localized 
in discreet lipid droplets mostly as TGs however, accumulation of intramyocellular lipids 
are markers for other lipid intermediates including ceramides, fatty acyl-CoA or 
diacylglycerols which in turn may directly impact the insulin signaling pathway through 
activation of signaling cascades that will inhibit the insulin stimulated glucose uptake 
such as serine phosphorylation of IRS-1 through upstream kinases such as PKCs, mTOR, 
p70 S6K and IKK/NFkB (117,51,49,55,128,129). 
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1.4 AMP-activated Protein Kinase Pathway (AMPK) 
 
AMPK is a 62 kDa serine/threonine kinase energy sensor that plays a crucial role 
in regulating energy balance within the cell. AMPK is a heterotrimer which is composed 
of catalytic  subunit and regulatory andsubunits (130). Homologues subunits of 
each AMPK have been found in every eukaryotic species including worms, fruit flies, 
yeast, fish and mammals (131). Different isoforms of AMPK subunits have been found in 
mammals including as well as
The N-terminal section of the  subunit of AMPK contains the serine/threonine 
kinase catalytic domain and the Thr172 residue which is phosphorylated and required for 
the activation of AMPK. The C-terminal segment of the catalytic subunit is essential 
for association of the and  subunits (133). Furthermore, the physiological function of 
both and  subunits of AMPK have not been extensively studied nevertheless, it has 
been found that  subunit acts as a scaffold to link the and  subunits together. Studies 
conducted in transgenic Hampshire pigs expressing the dominant Rendement Napole 
phenotype achieved by a single missense mutation (R225Q) of the  subunit of AMPK 
resulted in 70% decrease in glycogen content in muscle and higher oxidative capacity 
(134). Glycogen synthesis was significantly decreased after exercise in mice that 
underwent gene knockout of the subunit (135). Additionally, well established 
activators of AMPK failed to increase muscle glucose uptake and to protect against HFD-
induced accumulation of triglycerides in AMPK γ3 knock-out mice (135). These studies 
provide substantial evidence that the  subunit is involved in glucose metabolism and fat 
oxidation.  
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AMPK is activated as a result to an elevation in AMP/ATP ratio. Reduced ATP 
levels lead to an increase in AMPK activation as a result of increased muscle activity 
which leads to phosphorylation and inhibition of acetyl-CoA carboxylase (ACC). This 
inhibition causes reduction of malonyl-CoA levels which is a well-known inhibitor of 
carnitine palmitoyltransferase 1 (CPT 1) (136). Loss of CPT1 reduction causes promotion 
of fatty acid oxidation in muscle mitochondria which in turn leads to replenishment of 
ATP (132).  
AMPK may be activated and regulated by its upstream kinases including liver 
kinase B1, calcium/calmodulin-dependent protein kinase (CaMKK), transforming growth 
factor TGF) activated kinase (TAK1) as well as by sirtuin 1 (SIRT1) (131). 
Activation of AMPK by AICAR, antimycin A, and sodium azide was completely 
abolished in human fibroblasts lacking LKB1 expression (137,138). Additionally, AMPK 
activation by stimulation with small molecule PT1 is prevented by STO-609, an inhibitor 
of CaMKK, in L6 muscle cells (139). AICAR (5-amino 4-imidazolecarboximide 
riboside), muscle contraction, metformin and polyphenols such as resveratrol are 
established activators of AMPK. AICAR or metformin, had no effect on AMPK 
phosphorylation in mice embryos that underwent TAK1 knockout (140). Additionally, 
resveratrol-induced activation of AMPK was inhibited in the presence of splitomicin, an 
inhibitor of SIRT1 in hepatocytes (141). 
AMPK activation has a noteworthy impact in skeletal muscle and its activation 
triggers stimulation of glucose uptake, GLUT4 translocation, FA oxidation and 
mitochondrial biogenesis while reducing the rates of protein synthesis and glycogen 
storage (142). In recent years, AMPK activators have been recognized as promising 
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pharmacological interventions for the prevention and treatment of T2DM (143–149). 
Many reports indicate that in skeletal muscle both AICAR and contraction increase 
glucose uptake and insulin sensitivity through activation of AMPK resulting in GLUT4 
translocation to cell membrane (150–152). Additionally, wortmannin, an inhibitor of 
PI3K, did not have any effect on the AICAR- and contraction-stimulated glucose uptake 
indicating that the signaling mechanism is insulin-independent (150–152). Metformin, is 
a biguanide drug that is currently the first line of treatment for T2DM. Metformin 
activates AMPK indirectly through inhibiting complex 1 of the mitochondrial respiratory 
chain and promoting a switch to anaerobic glycolysis thus increasing the AMP/ATP ratio 
leading to AMPK activation (153). Metformin treatment induces AMPK activation 
leading to GLUT4 translocation and therefore increase the glucose uptake in L6 and 
C2C12 muscle cells (154,155), rodent muscle (155,156) and human muscle extracted 
from diabetic patients (155,157). Moreover, metformin delays the onset of T2DM and 
increases overall body insulin sensitivity by approximately 30% in T2DM subjects 
(155,158). Activation of AMPK, inhibition of hepatic glucose production and increased 
GLUT4 translocation to the plasma membrane in adipose tissue and skeletal muscle may 
in part be attributed to the mechanism of action of metformin in attenuating insulin 
resistance (155,158). Other compounds such as polyphenols are also found to activate 
AMPK. Studies have indicated that 5μg/ml of rosemary extract (RE), 2 μM carnosic acid 
(CA) and 5 μM rosmarinic acid (RA), major polyphenol found in RE, increased glucose 
uptake to levels comparable to insulin and metformin and activated AMPK in L6 muscle 
cells (160–162). In addition compound C (CC), an inhibitor of AMPK, significantly 
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inhibited the RE- and CA-stimulated glucose uptake indicating that activation of AMPK 
may be the mechanism in which these polyphenols increase glucose uptake (160,161).  
Recent evidence showed that AMPK activation may inhibit the NFkB signaling 
pathway mainly by deacetylation of the p65 protein of the NFkB complex (163). The 
NFkB subunits are not a direct target of AMPK however the inhibition of NFkB signaling 
is shown to be mediated by other AMPK targets such as SIRT1, peroxisome proliferator-
activated receptor-gamma coactivator-1 (PGC-1) and p53 (163). Chemical activation of 
AMPK by AICAR significantly inhibited NFkB activation and translocation to the 
nucleus in endothelial cells (164). Additionally, stimuli such as salicylate (aspirin) that 
activate AMPK inhibit IKK and therefore NFkB translocation to the nucleus 
(103,104,102).Taken together, the studies above indicate that AMPK plays a pivotal role 
in energy metabolism and glucose uptake in skeletal muscle and its activation may be 
critical in combating insulin resistance and glucose homeostasis.  
1.5 Rosemary and its phenolic compounds  
 
Rosemary (Rosmarinus officinalis) is a plant belonging to the labiate family 
(Lamiaceae). It is an aromatic evergreen shrub indigenous to the Mediterranean region 
and South America (165). The fresh and dried leaves are frequently used as a food 
preservative and in traditional Mediterranean cuisine as a flavoring agent. Historically 
rosemary has been used medicinally to treat renal colic, dysmenorrhea, to stimulate hair 
growth and relieve symptoms caused by respiratory disorders (165,166). Today, rosemary 
extracts (RE) are often used in aromatherapy, cosmetics, to treat anxiety-related 
conditions and increase alertness (166). RE contains different classes of polyphenols 
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including phenolic acids, flavonoids and phenolic terpenes (167–171) (Table 1). Phenolic 
acids include a) the hydroxycinnamic acids: rosmarinic acid, chlorogenic acid, coumaric 
acid, coumaroylqunic acid, ferulic acid, m-hydroxybenzoic acid and p-coumaric acid b) 
the hydroxybenzoic acids: caffeic acid, dicaffeoylquinic acid, gallic acid, protocatechuic 
acid, syringic acid, vanillic acid and c) the hydroxyphenylacetic acids: homovanillic acid 
and p-hydroxybenzoic acid. Flavonoids include a) the flavones: apigenin, apigenin-7-O-
glucoside, cirsimartin, genkwanin, homoplantaginin, ladanein, linaroside, luteolin, 
nepitrin, pectolinarigenin, scutellarein, salvigenin, tectochrysin, 4’5,7,8-
tetrahydroxyflavone b) the flavonols: kaempferol, kaempferol-3-O-rutinoside, quercetin, 
rutin, and c) flavanones: hesperetin, hesperidin and naringenin-C-hexoside. Phenolic 
terpenes found in rosemary include a) diterpenes such as carnosol, carnosic acid, 
epirosmanol, epiisorosmanol, isorosmanol, militirone, methyl carnosate, rosmadial, 
rosmanol, rosmaridiphenol, 7-α-methoxyroamanol, 7-β-methoxyroamanol and b) 
triterpenes: betulin, betulinic acid, oleanolic acid, urosolic acid, α-amyrin, β-amyrin and 
23-hydroxybetulinic acid (168,170–181). 
The polyphenols found in highest quantity in RE are carnosic acid (CA), carnosol 
(COH) and rosmarinic acid (RA) (171,182). The production of these polyphenols is 
influenced by growth conditions such as sunlight exposure, soil quality, and water 
availability (183). Furthermore, anatomical regions of this herbal plant have varying 
levels of total phenolic content whereby the leaves contain the highest concentration of 
polyphenols in comparison to stem, branch and flower regions (184). RE has been shown 
to have antioxidant, anti-inflammatory, anti-microbial, anti-tumorigenic, and anti-
hyperglycemic properties (185,186). These biological effects are highly correlated with 
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the polyphenolic content and CA, COH and RA are suggested to be responsible 
(185,186).  
1.5.1 Evidence of Anti-Diabetic Effects of Rosemary Extract: In Vitro Studies 
 
In vitro studies have shown that RE has an insulin-like effect to inhibit the 
production of glucose by hepatocytes. RE was shown to significantly suppress 
gluconeogenesis in HepG2 hepatocytes (187) (Table 2). In another study, RE was shown 
to significantly increase hepatocyte glucose uptake in a dose-dependent manner (188). CA, 
a major polyphenolic constituent of RE, prevented palmitate-induced lipid accumulation 
in hepatocytes (189) indicating that CA may potentially block cellular lipid accumulation 
in the long term and help against insulin resistance and T2DM. RE’s polyphenolic 
constituents may also provide protection against chemically-induced reactive oxygen 
species production and hepatocyte death. RA exhibited significant cytoprotective effects 
against mycotoxin-induced reactive oxygen species (ROS) production and induction of 
apoptosis by blocking effects on caspase-3 activation in hepatocytes (190). 
Treatment of 3T3-L1 adipocytes with RE (50 µg/ml) increased intracellular lipid 
levels and glucose uptake relative to the control (191). These effects of RE are similar to 
the lipid storing and glucose uptake effects of insulin in adipose tissue suggesting a 
potential of using RE against insulin resistance. In addition, it was reported that only CA 
and COH from all the major RE constituents, inhibited the differentiation of 3T3-L1 
preadipocytes into mature adipocytes (192). Another study indicated that treatment with 
RE (30 µg/ml) resulted in complete inhibition of 3T3-L1 differentiation and CA (0.3-20 
µM) alone exhibit a similar effect (193). In addition to the effects of RE on hepatic glucose 
production and adipocyte glucose uptake, RE has plays a role in intestinal glucose 
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absorption as well as carbohydrate digestion. Digestive enzymes such as amylase and α-
glucosidase play an important role in carbohydrate digestion and absorption by converting 
complex carbohydrates to simple sugars such as glucose and fructose. Intestinal α-
glucosidase allow glucose to be absorbed by the small intestine thereby increasing blood 
glucose levels. Inhibitors of α-glucosidase (acarbose, miglitol, voglibose) are used in the 
management of hyperglycemia present in T2DM. RE was found to have a significant α-
glucosidase inhibitory activity (194) which was the most potent among the other extracts 
of herbs and spices tested. Moreover, RE was demonstrated to significantly inhibit porcine 
pancreatic amylase activity (PPAM) in vitro (195). PPAM hydrolases dietary 
polysaccharides into less complex saccharides allowing further digestion. Additionally, 
RA, a major polyphenolic constituent of RE also significantly inhibited PPAM (196). 
Other effects of RE that may contribute to regulation of glucose homeostasis may be 
due to its effects on lipid/fat metabolism. Lipids are stored in our cells particularly 
adipocytes in the form of triglycerides (TG). The breakdown of TG is controlled by 
enzymes called lipases. Excessive activation of hormone sensitive lipase leads to increases 
in plasma lipid levels such as free fatty acids (FFA) contributing to insulin resistance and 
T2DM. The effects of RE were assessed on hormone sensitive lipase (HSL) and pancreatic 
lipase (PL), a key enzyme involved in fat digestion and was shown to significantly inhibit 
both enzymes in a dose-dependent manner in rat epididymal adipocytes (197). Pure RA 
was shown to inhibit PL and HSL in a dose dependent manner. Moreover, the extract had 
greater inhibitory activity compared to purified compounds suggesting that the extract 
contains a variety of constituents that may contribute synergistically in the inhibition of 
these enzymes (197). Additionally, in vitro analysis indicated that CA rich RE inhibited 
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PL activity by 70% (198). These studies clearly indicate that RE and its constituents CA 
and RA have in antilipolytic activity in vitro.  
Skeletal muscle tissue is important target of insulin and accounts for approximately 
80% of insulin mediated glucose uptake in the postprandial state. As a consequence, it 
plays a predominant role in glucose homeostasis. Treatment of L6 myotubes with RE 
increased glucose uptake in a dose- and time-dependent manner (160). Maximum 
stimulation of glucose uptake was seen with 5 µg/ml of RE was comparable to the 
maximum stimulation of glucose uptake by insulin or metformin (Table 2) (160). In 
addition, treatment of L6 myotubes with CA (20 µg/ml for 6 hours) resulted in significant 
increase in glucose uptake (199). Additionally, treatment with of L6 myotubes with CA 
(5µM for 4 hours) increased glucose uptake to levels comparable to insulin and metformin 
(161). Additionally, treatment with RA (5 M for 4 hours) significantly increased glucose 
uptake that was comparable to insulin and metformin (162). All of the above in vitro studies 
indicate that RE has the potential to affect key insulin target tissues (liver, fat, muscle) and 
directly induce anti-diabetic effects. 
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Table 2: Anti-diabetic effects of RE and its main polyphenolic constituents: in vitro 
studies 
 
Study Cell/Model Treatment Effects 
Yun et 
al.(187) 
HepG2 hepatocytes RE 100 µg/ml ↓ gluconeogenesis. 
Tu et al.(188) HepG2 hepatocytes RE 0.4, 2, 10, 50 
µg/ml  
↑ glucose uptake 
Wang et 
al.(189) 




HepG2 hepatocytes COH 20-40 µM ↓de novo formation of 
intracellular TG  
Renzulli et 
al.(190) 








3T3-L1 adipocytes CA 3 µM, COH 3 
µM 




3T3-L1 adipocytes RE 10-30 μg/ml 
CA 0.3-20 Μm 
↓ differentiation.  
Koga et 
al.(194) 
Rat intestinal α-glucosidase 
(AGc) 





Porcine Pancreatic α-amylase 
(PPAM) 




Porcine pancreatic α-amylase 
(PPAM) 




Rat epididymal adipocytes 
Porcine pancreatic lipase (PL); 
Hormone sensitive lipase (HSL) 
RE 6.3-200 µg/ml 
& its constituent 
RA 




Human PL  RE 100 µg/ml 
rich in CA 
↓PL by 70%  
Naimi et 
al.(160) 
L6 rat muscle cells RE 5 µg/mL for 4 
h 
↑ glucose uptake 
Lipina et 
al.(199) 
L6 rat muscle cells CA 20 µg/mL for 
6 h 
↑ glucose uptake 
Naimi et 
al.(161) 
L6 rat muscle cells CA 5 μM for 4 h ↑ glucose uptake 
Vlavcheski et 
al. (162) 
L6 rat muscle cells RA 5 μM for 4 h ↑ glucose uptake 
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1.5.2 Evidence of Anti-Diabetic Effects of Rosemary Extract: In Vivo Studies  
  
Several studies have been carried out in diabetic animal models to investigate the 
anti-hyperglycemic effects of RE (Table 3). In streptozotocin-(STZ) induced diabetic 
rats, administration of an aqueous RE resulted in significant decrease in fasting plasma 
glucose (FPG) level (201). In another study, administration of 50% ethanol extract of 
rosemary in STZ rats significantly decreased plasma glucose levels due to inhibition of 
glucosidase enzyme activity (194). In a more recent study, daily administration of 
aqueous RE (200 mg/kg) for three weeks caused significant reductions in blood glucose 
levels of both normal and STZ-induced diabetic rats (202). Similar effects were seen on 
blood glucose levels in STZ-induced diabetic rats given aqueous RE (4g/kg/day) for 4 
weeks (203). In addition, the extract significantly reduced plasma, FPG, TG, total 
cholesterol (TC) and low density lipoprotein (LDL) while increasing plasma high density 
lipoprotein (HDL) and erythrocytes levels. In agreement with the above studies, blood 
glucose levels as well as TC and TG levels were significantly reduced in STZ-induced 
diabetic rats given aqueous RE (200 mg/kg/day) 2 weeks before and 2 weeks after STZ 
injection (204,205). Furthermore, administration of aqueous extract of rosemary prior to 
streptozotocin injection in rats significantly protected against STZ-induced elevations in 
blood glucose levels which was correlated with a significant protection against pancreatic 
β-cell loss (206). Administration of dried rosemary leaves for approximately 6 weeks in 
STZ-induced diabetic and healthy Sprague Dawley rats decreased the FPG, glycated 
hemoglobin (HbA1c), TC and TG and LDL levels in STZ-induced rats without effecting 
the plasma glucose levels or the lipid profile in the control group (207). 
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In addition to the STZ-induced diabetic model, the alloxan-induced diabetes animal 
model is also used extensively. Alloxan causes diabetes by rapid depletion of pancreatic 
β-cells leading to inflammation and sustained hyperglycemia secondary to a reduction in 
insulin release into circulation. In alloxan-induced diabetic rabbits, ethanol RE (200 
mg/kg) lead to a significant reduction in FPG (208). In contrast, another study indicated 
that intramuscular administration of volatile oil of RE leaves inhibited insulin release and 
increased blood glucose levels leading to hyperglycemia in normal and alloxan-induced 
diabetic rabbits (209). In another study, oral administration of powdered RE added as 
20% of diet or 20% aqueous RE to alloxan induced diabetic rats significantly decreased 
the fasting plasma glucose levels compared to control and the treatment demonstrated to 
reduce alloxan-induced hepatocyte vacuolar degeneration, necrosis, small hemorrhages 
and dilatation of hepatic sinusoids indicating hepatoprotective effects (210). Moreover, 
administration of RA (100-200 mg/kg) to alloxan-induced rats for eight weeks 
significantly inhibited glomerular hypertrophy, glomerular number loss and 
glomerulosclerosis compared with diabetic control indicating RA’s renoprotective 
properties (211). Administration of 250 and 500 mg/kg/day of RE mixed with water 
(70%) for 63 days in male rats did not affect serum blood glucose, TG, TC levels or body 
weight but testosterone levels, spermatogenesis, sperm density and motility were 
significantly decreased (212). In addition, alanine aminotransferase (ALT) and aspartate 
aminotransferase (AST), enzymes released due to liver damage, were also decreased. 
Oral administration of CA (approximately 17mg/kg/day) to obese leptin receptor 
deficient mice for five weeks resulted in significant protection against fat-induced fasting 
and non-fasting hyperglycemia, improved glucose tolerance as well as decreased serum 
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insulin levels (213). CA also significantly inhibited weight gain, decreased regional areas 
of visceral fat, and prevented against fat accumulation in white adipose tissue as well as 
liver. Moreover, animals supplemented with CA exhibited decreased serum levels of 
triglycerides, cholesterol, and ALT as well as significantly decreasing hepatic lipid storage 
(213). 
Apart from animal models of genetic and chemically-induced obesity and T2DM, 
the effects of RE have been examined in dietary animal models of obesity and T2DM. 
Daily, dietary supplementation of RE (500 mg/kg) standardized to contain 20% CA for 16 
weeks in mice that were started on a high-fat diet (HFD) as juveniles significantly protected 
against HFD-induced elevations in plasma glucose and TC levels compared with HFD 
control mice (198). Notably, fasting insulinemia remained low during the length of the 
study and no significant differences were observed between the groups. Correlating with 
the observed reductions in total cholesterol levels, HFD mice supplemented with RE 
displayed significant decreases in fat mass and one to twofold increase in total fecal lipid 
content compared to HFD-fed control mice (198). Additionally, another study indicated 
that administration CA (20 mg/kg) in 5-20 mg/kg olive oil loaded mice, significantly 
repressed the elevation of TG levels, prevented epididymal fat gain and inhibited pancreatic 
lipase activity (214). Administration of 200 mg/kg of RE for 50 days in mice fed high fat 
diet, resulted in reduced b.w and fat mass and increase of fecal lipid excretion, while 
hepatic triglyceride content was decreased (215). Similarly, daily administration of 
aqueous RE (100 mg/kg b.w) to high-cholesterol fed mice for 36 days resulted in 
significant decline in plasma TG, TC, LDL levels, while HDL levels were increased 
compared to control mice (216). Furthermore, administration of aqueous RE (70-140 
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mg/kg b.w) and non-esterified phenolic RE (7 to 14 mg/kg b.w) for four weeks resulting 
in significant reduction in TC and non-HDL levels compared to control (217). High-
fructose fed (HFR) mice given daily dose of RA (100 mg/kg b.w) for 60 days decreased 
fasting plasma glucose levels, improved glucose tolerance and reduced plasma insulin and 
glycated HbA1c levels (218). In contrast, obese mice and their lean counterparts fed 0.5% 
ethanol extract of rosemary enriched with CA (40%) incorporated in their standard chow 
for 64 days did not show significant differences in their glucose levels compared to control 
rats, although circulating insulin levels were found to be significantly decreased only in the 
lean rats (219). Noteworthy, the plasma glucose levels in all animals were within normal 
physiological range with a non-significant, slight increase in obese counterparts. The study 
also demonstrated a significant inhibition of gastric lipase (GL) in the stomach and 
pancreatic lipase (PL) in small intestine of rats consuming the RE(219) Furthermore, there 
was a significant attenuation of circulating plasma TNF-α, IL-1β, leptin and elevation of 
adiponectin levels (Table 3) (220). 
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Table 3: Anti-diabetic effects of RE and its main polyphenolic constituents: in vivo 
studies  






Ad libitum (10 
g leaves of 
rosemary in 1 
L boiling 










Koga et al.(194) STZ-induced 
diabetic male  
ddY mice 












for 3 weeks 
↓ FPG ↑vitamin C 
 




4g/kg/day for 4 
weeks 




albino rats  
RE aqueous, 
200 mg/kg/day 
2 weeks prior 























2 weeks prior 
and 3 weeks 
after STZ  

























200 mg/kg for 
6 hours (acute); 
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powdered food  
for 45 days 
↓FPG ↓hepatocyte necrosis  













↓creatinine and urea 
↓glomerular number  
























Wang et al.(213) Male ob/ob mice CA 
17mg/kg/day  







↓TC (24%)  
↓TG (60%) 
↓plasma FFA (13%) 
↓hepatic lipids 
↓ALT (64%) 










↑fecal total lipid 







treated male ddY 
mice 
CA 20 mg/kg 
for 14 days 
COH 200 
mg/kg for 14 
days 
 ↓body weight (7%)  
↑epidydimal fat  
↓pancreatic lipase 
(IC50 12 and 4.4 






RE 20 or 200 
mg/kg/day for 
50 days 





↓body weight and fat 
mass (64% and 57%) 
↓Hepatic TG (39 %) 
↔ serum TG and TC 
↑fecal lipid excretion  







for 36 days 





Wistar rats  
RE aqueous,  
70-140 
mg/kg/day 
 ↓TC (39.8%) 
↓non-HDL (44.4%) 



























Female Zucker lean 
(fa/+) and obese 
(fa/fa) rats  
RE ethanol, 
enriched with 






levels in lean 
animals 
↓TC, TG, LDL 
↑HDL 
↓leptin, TNF-α, IL-1β 
(lean rats) 
↓gastric lipase activity  
 
1.5.3 Evidence of Anti-Hyperglycemic Effects of Rosemary: Human studies 
 
In addition to numerous in vitro cellular studies and in vivo animal studies, RE 
has been recently investigated in humans. Healthy participants were randomly selected 
into 3 groups and treated with 2, 5 or 10g/day of dried rosemary leaf powder for 8 weeks 
(221) (Table 4). Blood samples were taken from participants before and after the study. 
FPG was decreased by 18.25, 15.74 and 11.2% in the 10, 5 and 2g/day group 
respectively. TC levels were significantly decreased by 34.48% in the 10g/day group and 
17.97% and 11.48% in the 5g/day and 2g/day respectively. LDL cholesterol in this group 
was also significantly lowered by 32.28% in the 10g/day treated group and 28.46% and 
15.58 % in the 5g/day and 2g/day respectively. Additionally, HDL cholesterol was 
increased by 22.91% in the 10g/day group and 15.21% and 4.54% in the 5g/day and 
2g/day respectively. Furthermore, triglyceride levels were also decreased by 29.06% in 
the 10g/day group and 21.3% and 14.97% in the 5g/day and 2g/day treated group 
respectively. In addition to the improvement in the overall lipid profile rosemary powder 
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seems to exhibit high antioxidant prosperities by decreasing malonaldehyde (MDA) by 
36.21%, 12.43% and 13.6% in the 10g/day, 5g/day and 2g/day treated groups 
respectively. Glutathione reductase (GR) was decreased by 15.36%, 6.73%, and 0.95% in 
the 10g/day, 5g/day and 2g/day treated groups respectively. Additionally, there have been 
a few studies indirectly examining the effects of rosemary supplements with non-
conclusive results. An observational, prospective, monocenter study examined the effect 
of 21 days of oral supplementation of aqueous RE (containing 77.7 mg RE with 0.97 mg 
COH, 8.60 mg CA, and 10.30 mg RA) in twelve healthy young volunteers found a 
significant decrease in plasminogen activator-inhibitor-1 (PAI-1) levels suggesting that 
RE may have anti-inflammatory and anti-blood clotting activity in vivo (222). Another 
observational study demonstrated that administration of RE and oleanolic acid, (440 mg 
thrice a day for 4 weeks and additional 880 mg twice a day for 4 weeks) in patients with 
osteoarthritis, fibromyalgia, and rheumatoid arthritis, was protective against 
inflammatory rheumatic diseases particularly in those with initial serum c-reactive 










Table 4: Anti-diabetic and antioxidant properties of RE: Human studies 
Reference  Study methodology Treatment  Effect 
Labban et 
al.(221) 
48 healthy individuals Dry rosemary powder  





↓MDA, ↓GR,  




12 healthy, young volunteers RE 77.7 mg  
COH 0.97 mg 
CA 8.6 mg 
RA 10.30 mg for 21 
days 





72 patients with rheumatic disease 
including osteoarthritis (OA), 
rheumatoid arthritis (RA) and 
fibromyalgia (FM). 
Meta050 compound 
(RE, oleanolic acid and 
reduced iso-alpha-
acids) 
440 mg/day for 4 
weeks 3 times per day 
880 mg/day for 4 
weeks 2 times per day. 
↓CRP  








 Skeletal muscle is quantitatively the most significant target tissue of insulin and 
therefore plays an important role in glucose homeostasis. Impairments in insulin 
signaling in skeletal muscle leads to insulin resistance and T2DM. Increased plasma 
FFAs such as palmitate have been linked to insulin resistance in vitro and in vivo (52). 
Elevated free fatty acids (FFAs) in the blood, as seen in obesity, impair insulin action in 
muscle leading to insulin resistance and Type 2 diabetes mellitus. Serine phosphorylation 
of the insulin receptor and insulin receptor substrates (IRS) reduces insulin-stimulated 
tyrosine phosphorylation and insulin action. Protein kinases including GSK3 (40), JNK 
(41, 42), PKC’s (66), mTOR (45), p70 S6K (47) have been found to be implicated in 
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FFA-induced insulin resistance both in vitro and in vivo. Several studies that used L6 and 
C2C12 skeletal muscle cells have indicated that palmitate elevates ceramide production, 
increases phosphorylation of Ser307 and Ser636/639 of IRS-1 leading to impairment in 
the insulin signaling (52,100). The above mentioned protein kinases can lead to 
phosphorylation of Ser307 and Ser636/639 residues of the IRS-1 which in turns impairs 
the downstream insulin signaling cascade thus significantly reducing the insulin 
stimulated glucose uptake (51). Additionally, studies have found that obese individuals 
with an increased FFA plasma levels have shown a significant reduction in the insulin-
induced glucose uptake (51,224). 
The biological effects of the polyphenols ignited an interest from the scientific 
community to be used as nutraceuticals to counteract different diseases. Rosemary extract 
and rosemary polyphenols have been shown to increase glucose uptake in skeletal muscle 
cells (160,161) and prevented high fat diet-induced insulin resistance in mice (198,213). 
However, the effects of RE and RE polyphenols have never been examined in FFA-
induced insulin resistance in L6 muscle cells. Therefore, the exact mechanism of RE 
action needs to be elucidated by further investigating the key signaling molecules that 
may exhibit antidiabetic properties. Understanding the mechanism is required in order to 
enhance the potential of RE to be used as a preventative/therapeutic treatment strategy for 











In the current thesis we hypothesize that: 
1) Rosemary extract and its polyphenols CA, RA and COH prevent the palmitate-induced 
skeletal muscle insulin resistance.  
2) Rosemary extract ameliorates the palmitate-induced IRS-l Ser307 & Ser636/639 
phosphorylation 
3) Rosemary extract ameliorates the palmitate-induced decrease in insulin-stimulated Akt 
phosphorylation. 
4) Rosemary extract attenuates the FFA-induced increase in JNK, mTOR and p70 S6K. 
5) Rosemary extract increases AMPK activation and AMPK may play a role in the RE 
and RE polyphenol-mediated effects. 
1.8 Significance:  
 Currently there is no cure for diabetes mellitus however the treatment strategy 
usually includes managing and alleviation of the underlying pathological processes with 
life style changes such as regular exercise and healthy diet together with pharmacological 
interventions. Oral medication for the treatment of T2DM include sulfonylureas and 
meglitinides that stimulate insulin release from the β-cells, α-glucosidase inhibitors that 
inhibit intestinal glucose absorption, biuanides and thiazolidinediones that increase 
peripheral glucose transport and inhibit the hepatic glucose output via gluconeogenesis. 
However, despite the different treatment strategies available there is lack of drug efficacy 
which is accompanied by many unwanted side-effects. For instance, metformin, a 
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biguanide drug that is prescribed as a first line of treatment for T2DM is highly 
associated with acidosis and gastrointestinal issues such as diarrhea, nausea, vomiting and 
cramps (225). Overall, there is a continued interest for more effective treatment with less 
side-effects despite the medications available for the management of T2DM. Around 
50% of the affected individuals with T2DM are living in poverty stricken area in Asia 
and Africa. As a result, there is pressing need for a more effective and less expensive 
treatment. The study of novel agents that can exhibit an insulin-like effect, improve 
insulin sensitivity and efficacy of treatment with less adverse effects that will broaden the 
spectrum of preventative and treatment options for T2DM is highly desired. The use of 
plants for healing purposes forms the origin of modern medicine. Moreover, the use of 
phytotherapy has been on the rise in the developed world considering that many 
conventional drugs such as aspirin (from willow tree bark) and morphine (opium poppy) 
as well as metformin (French lilac) have been extracted from plants. Together with the 
limited studies performed in humans, all the available information up to now provide 
evidence of antidiabetic, antioxidant and anti-inflammatory activities of RE in 
streptozotocin-induced diabetic mice (226), rats (205,206,227), alloxan-induced diabetic 
rabbits (228), genetic (229), and dietary (227,230,231) animal models of obesity and 
insulin resistance. The promising findings from in vitro and in vivo models suggest that 
RE and its polyphenols may be used as an agent for the management of diabetes. 
Investigating the effects of RE and RE polyphenols in vitro is needed in order to delineate 
their effects in different cells and tissue types thereby providing more evidence about its 
mechanism of action. On the other hand, clinical trials conducted on humans may be 
required to elucidate their therapeutic potential against insulin resistance.  
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Fetal Bovine Serum (FBS), rosmarinic acid, dimethyl sulfoxide (DMSO), o-
phenylenediamine dihydrochloride (OPD) and cytochalasin B, were purchased from 
Sigma Life Sciences (St. Louis, MO). Materials for cell culture were purchased from 
GIBCO Life Technologies (Burlington ON). Anti-c-myc antibodies and Peroxidase-
conjugated Goat anti-rabbit IgG were purchased from Sigma Life Sciences and Jackson 
ImmunoResearch Labs, (West Grove, PA. St. Louis, MO. Mississauga, ON respectively). 
Phospho- and total AMPK, Akt and HRP-conjugated anti-rabbit antibodies were 
purchased from New England BioLabs (NEB) (Missisauga, ON). Insulin (Humulin R) 
was from Eli Lilly (Indianapolis, IN). Compound C and wortmannin were purchased 
from Calbiochem (Gibbstown, NJ, USA). Luminol Enhancer reagents, polyvinylidene 
difluoride (PVDF) membrane, reagents for electrophoresis and Bradford protein assay 
were purchased from BioRad (Hercules, CA). BioRad. [3H]-2-deoxy-D-glucose was 
purchased from PerkinElmer (Boston, MA).  
2.2 Cells  
 
The L6 skeletal muscle cells are an immortalized myogenic cell line obtained 
from rat hindlimb. The cells undertake the process of proliferation when grown in α-
minimum essential media (α-MEM) containing 10% fetal bovine serum (FBS) and 
undergo spontaneous differentiation into multinucleated myotubes by placing them into 
α-MEM containing 2% FBS. L6 skeletal cells can grow in monolayers which makes them 
accessible to biologically active compounds/chemicals rendering them a good model for 
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investigating their effects. Additionally, they express both insulin receptor and insulin-
like growth factor receptor (IGF-1) along with facilitated glucose transporters (GLUTs) 
such as GLUT1, GLUT3 and GLUT4 (241). Throughout the differentiation stage from 
myoblasts to myotubes, the expression of the insulin receptor as well as GLUTs 
transporters increases which results in insulin responsiveness (232,233). After insulin 
treatment, all three GLUTs expressed in the cell undergoing translocation to the cell 
membrane however GLUT4 is the transporter that is greatly affected by the insulin action 
(242). In agreement with the changes in GLUTs expression observed between the 
myoblast and myotube stage, the transport of glucose is also different as the cell 
differentiates. The basal glucose transport is highest in myoblast whereas insulin-induced 
glucose uptake is detected only after cell alignment and further increases as the cells 
differentiate to a myotube phase (243).  
Cells in culture has been extensively used in order to investigate different 
hormonal and metabolic processes. There are several advantages in regards to using cells 
in culture. For instance, the cells in culture are a homogeneous population with small 
intracellular spaces unlike intact tissue preparation in addition to tightly controlled 
external environment and with absence of external factors found in vivo that could 
possibly interfere with the actual effect of the treatment. Furthermore, in vitro models are 
well-recognized when examining numerous acute and chronic treatments. Specifically, in 
this study L6 muscle cells were chosen considering that the palmitate-induced insulin 
resistant model was previously established in our lab. Isolation of human skeletal muscle 
strips are only possible during surgical procedures thus their availability is quite limited. 
In addition, there is a great risk of damaging the membrane integrity after harvesting the 
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muscle tissue (234). In primary cell culture stimulation with physiological concentration 
of insulin was not demonstrated to be effective. Moreover, establishing primary culture 
can be difficult and arduous process. Primary cell culture is not generally used taking into 
consideration that it is extremely sensitive and requires additional nutrients which need to 
be specifically customized for each cell type thereby increasing the cost. 
Other than the L6 muscle cells, C2C12 are also insulin responsive and contain 
GLUT1 and GLUT4 transporters (234). However, the insulin responsiveness and the 
GLUTs content is much lower in comparison to L6 and C2C12 are usually implicated in 
studies that utilize contraction as a form of stimulation (235,236). 
Although L6 muscle cells exhibit similar characteristics to skeletal muscle it is 
important to note that they are not identical. For instance, the actin network of L6 
myotubes does not form the contractile sarcomeres found in skeletal muscle and the fully 
differentiated cells do not replicate the physiological interactions between the cells as 
seen in vivo. Additionally, the insulin-stimulated glucose uptake in L6 is lower compared 
to skeletal muscle (2 fold increase vs 4-5 fold respectively) (237).  
Despite these differences L6 muscle cells exhibit many similarities to skeletal 
muscle (as mentioned above). Therefore, they provide a good model for investigating the 
mechanism of insulin action and different compounds that may affect glucose uptake and 
metabolism.  
2.3 Cell Culture Technique  
L6 muscle cells were grown in a 250 cm3 flasks containing -MEM media (pH 
7.4) supplemented with 10% FBS (v/v), 1% antibiotic-antimycotic cocktail solution (100 
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U/ml penicillin, 100 g/ml streptomycin and 250 ng/ml amphotericin B) and 5mM 
glucose until 60-70% confluency was reached. The myoblasts were then trypsinized, 
counted with a hemocytometer and 100 000-120 000 cells/ml (cells/well) were seeded in 
12 or 6 well tissue culture plates in -MEM containing 10% FBS (v/v) and 1% antibiotic-
antimycotic cocktail solution. The 12 well plate contained 1 ml of cells with media and 
was used for glucose uptake measurements and the 6 well plate contained 2 ml of cells 
with media and was used for western blotting analysis. After the cells reached 100% 
confluency the cells were exposed to a 2% FBS (v/v) and 1% antibiotic-antimycotic 
cocktail containing media solution to allow the myoblasts to differentiate into myotubes. 
Fresh media was introduced every 48 hours and the cells were maintained for 5-6 days 
until becoming fully confluent differentiated myotubes. 
Serum deprivation for 18 hours was performed in all experiments. The rate of the 
basal glucose transport is decreased by serum deprivation (238) thus the cells are not at 
their maximum transport capacity prior to stimulation. As a result, the increase in glucose 
uptake in response to treatment is more detectable.  
After the treatment was completed, the cells were rinsed with HBS followed by 
glucose transport assay or cell lysis for western blotting. Stock solutions of RE and its 
polyphenols such as CA, RA were made by dissolving the powder in sterile DMSO. The 
cells were never exposed to more than 0.1% DMSO. Therefore, in parallel to the 
treatment group, a vehicle-treated group (0.0051% of DMSO) was used as a control. 
Insulin stock solution was prepared in -MEM containing 2% FBS (v/v). Palmitate 
solution was conjugated with fatty acid-free bovine serum albumin (BSA) (Sigma, St. 
Louis, MO)  
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2.4 Preparation of Palmitate Stock 
  
500 mL of distilled water was placed to boil in a 1000 mL size beaker and a water 
bath was pre-warmed at 45 degrees Celsius. 41 mg of palmitic acid was weighed out and 
transferred into a scintillation vial. Cut out Styrofoam was used to allow the vial to float 
on top of the boiling water. In a separate 50 mL vial 1.94g of BSA was dissolved in 20 
mL of distilled water to make up 9.7% BSA solution. The solution was then vortexed and 
placed into a 45-50 degrees Celsius water bath followed by placing the scintillation vial 
containing the palmitic acid into the boiling water. Once the palmitic acid vial is in the 
boiling water 15mL vial containing 0.1 N NaOH was added to the hot water until the 
NaOH solution started to bubble. Once the palmitic acid was melted, 1.6 mL of 0.1 N 
NaOH was transferred into palmitic acid vial and allowed to dissolve. The solution was 
then transferred to a pre-warmed up water bath and allowed to equilibrate. Once the 
solution is in the water bath 18.4 mL of the pre-warmed BSA was quickly added to the 
vial to give a final stock of 8mM of palmitate solution. The final molar ration of free 
palmitate vs BSA was 6:1.  
2.5 Preparation of Rosemary Extract (RE)  
 
Following previously established protocols by the National Cancer Institute of the 
US (223, 226 from Madina) whole dried Rosemary leaves (Rosmarinus officinalis L.) 
(Compliments, Sobey’s Missisauga, ON, Canada) were grounded and passed through a 
mesh sieve. 5 grams of ground leaves were steeped for 16 hours in dichloromethane-
methanol (1:1) (30 mL). Under a slight vacuum the filtrate was collected followed by 
methanol (30 mL) extraction for 30 min. The solvent was removed using rotary 
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evaporator. Aliquots of the extract dissolved in dimethyl sulfoxide (DMSO) were 
prepared (100 g/ml) and were stored at -20˚C (226).  
2.6 Cell Treatment  
L6 myotubes were serum deprived for 18 hours in the absence and presence of 5 
g/ml RE, 2 CA, 5 M RA and 25 M COH for 2 hours followed by treatment with 
0.2 mM of palmitate for 16 hours. Cells were exposed to 100 nM insulin for 0.5 hours. A 
vehicle-treated control (0.0051% of DMSO) was used in parallel with the treated groups.  
2.7 Glucose Uptake Assay  
 
The glucose uptake assay is a radiometric assay measuring the specific GLUT 
transporter-mediated glucose uptake using [3H]-2-deoxy-D-glucose, a non metabolizable 
glucose analog. After the incubation the cells were washed 3 times with HEPES-buffered 
saline solution (HBS) containing 20 mM HEPES, 5mM KCl, 2.5mM MgSO4, 1mM 
CaCl2 and 14mM NaCl, pH 7.4. Following the washing, 2-deoxy-D-glucose uptake 
measurements were performed by exposing the cells to 250µl of HBS containing 10µM 
[3H]-2-deoxy-D-glucose for precisely 10 minutes. Measurements of nonspecific uptake 
of 2-deoxyD-glucose were achieved by exposing the cells to 10µM cytochalasin B 
(GLUT inhibitor). The specific uptake was obtained by subtracting the nonspecific from 
the total uptake (in the absence of cytochalasin B). The glucose uptake was terminated by 
placing the cells on ice followed by washing the cells 3 times with 1 mL of ice cold 0.9% 
NaCl solution and finally lysed with a 1 mL of 0.05N NaOH solution. The cell lysates 
were placed into scintillation vials followed by addition of 10 mL of scintillation fluid. 
The experiments were always performed in triplicates and as many times as indicated in 
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each figure. Radioactivity was measured using a ScintiCount (PerkinElmer) Scintillation 
Counter. The results are shown as percentage of control for each individual experiment.  
2.8 Preparation of Cell Lysates for Western Blotting 
 
L6 muscle cells grown in 6-well plates until differentiated into myotubes. After 
treatment, the cells were rinsed 2 times with PBS and placed on ice. PBS was aspirated 
and followed by addition of 100µl of cell lysis buffer (20mM Tris (pH 7.5), l50 mM 
NaCI, 1 mM EDTA, 1mM EGTA, 1% Triton X-100, 2.5mM sodium pyrophosphate, 1 
mM p-glycerolphosphate, 1 mM Na3V04, 1 g/ml leupeptin, add 1 mM PMSF before 
use and chill on ice) to each well. The cell lysates were collected into 1.5 mL eppendorf 
tube, protein assay was performed along with addition of equal amount of sodium 
dodecyl sulfate (SDS) buffer (62.5 mM Tris-HCI (pH 6.8), 2% w/v SDS, 10% glycerol, 
0.01 % bromophenol blue, add 0.05% p-mercaptoethanol before use). The lysates were 
then boiled for 5 minutes and stored in -20 °C.  
2.9 Protein Assay  
 
Protein assay dye was purchased from BioRad and used to determine protein 
concentration on cell lystes. BSA protein standards were used in order to create a 
standard protein curve including 0, 0.1, 0.2, 0.4, 0.6, 0.8, 0.9, 1.0 mg/ml. Measurements 
were performed in triplicates where 10µl of each protein standard and lysed sample were 
pipetted into separate wells of a 96 well plate following by addition of 200µl of protein 
assay dye in each well. The plate was incubated at room temperature for 5 minutes which 
was followed by absorbance measurements in a microplate reader at 595nm. The final 
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concentration of the protein samples was calculated using Microsoft Excel and was used 
to determine the loading the same amount of protein during western blot analysis. 
2.10 Western Blot Analysis  
 
After treatment, the cells were washed three times with HBS and lysed with lysis 
buffer containing 150mM NaCI, 20mM Tris (pH 7.5), 1mM EDTA, 1% Triton X-100, 
1mM EGTA 2.5mM NA407P2, 1mM Na3V04 1Mm, β-glycerolphosphate, 1mM PMSF, 
1µg/ml leupeptin. The cells were scraped off and solubilized in electrophoresis (running) 
buffer which was followed by separation by sodium dodecyl sulfate (SDS) 
polyacrylamide gel (10%) electrophoresis. Each sample loaded contained 15 g/ml of 
protein. The samples were then transferred electrophoretically to PVDF membranes. The 
membranes were placed in 5% (w/v) nonfat dry milk in Tris-buffered saline blocking 
followed by overnight incubation with primary antibody at 4°C. The total and 
phosphorylated forms of the proteins were detected by immunoblotting on separate 
PVDF membranes. The primary antibody were detected by HRP-conjugated antirabbit 
secondary antibody (1:2000). LumiGLOW reagent purchased from New England Biolabs 
and Alpha Innotech FluorChem (quantitative imaging system for fluorescent and 
chemiluminescent blots (Johannesburg, S.A) were used to develop the blots. The 
densitometry of the bands, expressed in arbitrary units, was calculated using image J. The 
results are shown as percentage of control for each individual experiment. 
2.11 Statistical Analysis 
  
Statistical analysis was completed using GraphPad Prism software 5.3. The data 
from several experiments were pooled and presented as mean ± standard error (SE). The 
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means of all the groups were obtained and compared to the control group using one-way 
analysis of variance (ANOVA) which was followed by Tukey’s post hoc test for multiple 
comparison. 
CHAPTER 3: RESULTS 
 
3.1 Rosemary extract restores the insulin-stimulated glucose uptake in palmitate 
treated muscle cells 
 
 The effects of the free-fatty acid palmitate on insulin-stimulated glucose uptake in 
L6 myotubes was examined. Acute insulin stimulation (100 nM, 30 min) of the myotubes 
significantly increased the [3H]-2-deoxy-D-glucose uptake (201±1.21% of control, 
P<0.001, Figure 4). Exposure of the cells to palmitate (0.2 mM, 16 hours) resulted in 
significant reduction of insulin-stimulated glucose uptake (117±15.6% of control) which 
indicates insulin resistance. Exposure of the cells to RE (5 g/ml) alone resulted in 
significant increase in [3H]-2-deoxy-D-glucose uptake (208±15.6% of control, P<0.001). 
Most importantly in palmitate-treated cells, exposure to RE resulted in significant 
restoration of insulin stimulated glucose uptake (179±10.5% of control, P<0.001, Figure 
4). These data clearly indicate that the negative effect imposed by palmitate treatment is 
significantly ameliorated in the presence of RE. In addition, treatment with palmitate 
alone did not have any effect on the basal glucose uptake in comparison to the control 
group (103±2.7% of control) (Figure 4).  




Figure 4: Rosemary extract restores insulin-stimulated glucose uptake in palmitate 
treated muscle cells. Fully differentiated myotubes were treated without (control, C) or 
with 5 g/ml rosemary extract (RE) for 2 hours followed by treatment without or with 0.2 
mM of palmitate (P) for 16 hours and stimulation without or with 100 nM insulin (I) for 
30 min. [3H]-2-deoxy-D-glucose uptake measurements were performed as indicated in 
the method section. The results are the mean of 4-7 independent experiments, each 
performed in triplicate and expressed as percent of control (*** P<0.001 vs. control, ### 
P<0.001 vs. insulin alone).  
3.2 Rosemary extract prevents the palmitate-induced Ser307 and Ser636/639 
phosphorylation of IRS-1. 
 
After we established insulin resistance at the glucose uptake level, we investigated 
the effects of palmitate and RE downstream of the insulin receptor therefore the 
phosphorylation and expression of the IRS-1 was examined. Previous in vitro studies 
conducted in L6 muscle cells and rat muscle in vivo have indicated that increased 
phosphorylation levels of Ser307 and Ser636/639 of IRS-1 leads to impairment in the 
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insulin signaling leading to insulin resistance (64,94). We investigated the 
phosphorylation of the IRS-1 protein on Ser307 and Ser636/639 residues using specific 
antibodies. Exposure of L6 myotubes to 0.2 mM palmitate resulted in significant increase 
in Ser307 and Ser636/639 phosphorylation of IRS-1 (199.4±24.98%, 162±6.74% of 
control, P<0.001, P<0.01 respectively) (Figure 5). Treatment with 5 g/ml RE did not 
have any effect on the basal Ser307 or Ser636/639 phosphorylation (118±11.24%, 
105±3.51% of control respectively) but completely abolished the palmitate-induced 
increase in Ser307 and Ser636/639 phosphorylation of IRS-1 (108±16.91% of control and 
107±7.32% of control). The total levels of IRS-1 were not impacted by the treatments (P: 
103.3±8.63, RE: 98.82±13.21, RE+P: 108±9.33) (Figure 5). These data indicate that 
exposure to palmitate significantly increased serine phosphorylation of IRS-1 and 
treatment with RE completely abolished this effect. 
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Figure 5: Effects of palmitate and RE on IRS-l expression and Ser307, Ser636/639 
phosphorylation. Fully differentiated myotubes were treated without (control, C) or with 
5 g/ml RE for 2 hours followed by treatment without or with 0.2 mM of palmitate (P) 
for 16 hours and stimulation without or with 100 nM insulin (I) for 15 min. After 
treatment, the cells were lysed and SDS-PAGE was performed, followed by 
immunoblotting with specific antibodies that recognize phosphorylated (Ser307, 
Ser636/639) or total IRS-1. A representative immunoblot is shown. The densitometry of 
the bands, expressed in arbitrary units, was calculated using image J. The values are the 
mean ± SE of three separate experiments (*** P<0.001, ** P<0.01 vs. control, ### 
P<0.001 vs. palmitate alone). 
3.3 Rosemary extract restores the insulin-stimulated Akt phosphorylation in 
palmitate treated myotubes 
 
Next we investigated the effect of palmitate on insulin stimulated Akt 
phosphorylation and expression in the absence or presence of RE. Treatment of L6 
myotubes with insulin resulted in a significant increase in Akt Ser473 and Thr308 
phosphorylation (I: 312±19.21 and 289±23.12% of control respectively, p<0.001) as 
established by our group and others (162,161,239,234). Treatment of the cells with 
palmitate significantly attenuated the insulin-stimulated Akt phosphorylation on Ser473 
and Thr308 residues (P+I: 121.9±31.30 and 131±35.90% of control respectively, 
p<0.001) (Figure 6) which is in accordance with other studies (100). Palmitate and RE 
alone did not have any effect on the basal Ser473 or Thr308 Akt phosphorylation (P: 
98.2±3.02, 95±6.20, RE: 103±4.10, 105±6.2%, RE+P: 109.1±9.06, 111±5.92% of 
control, respectively). However, in the presence of RE, the decline in the insulin-
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stimulated Akt phosphorylation on Ser473 and Thr308 with palmitate was completely 
prevented (RE+P+I: 346.7±66 and 312±30.31% of control respectively, P<0.001 (Figure 
6). The total levels of Akt were not significantly affected by any of the treatments (I: 
108±8.4, P: 99 ± 5.9, P+I: 101±11.6, RE: 94±5.72, RE+P: 93.6±7.2, RE+P+I: 93±15.23% 
of control) (Figure 6). 
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Figure 6: Effects of palmitate and RE on Akt expression and Ser473 and Thr308 
phosphorylation. Fully differentiated myotubes were treated without (control, C) or with 
5 g/ml rosemary extract (RE) for 2 hours followed by treatment without or with 0.2 mM 
of palmitate (P) for 16 hours and stimulation without or with 100 nM insulin (I) for 15 
min. After exposure to treatment, the cells were lysed and SDS-PAGE was performed, 
followed by immunoblotting with specific antibodies that recognize phosphorylated 
Ser473, Thr308 or total Akt. A representative immunoblot is shown. The densitometry of 
the bands, expressed in arbitrary units, was calculated using image J. The values are the 
mean ± SE of three separate experiments (*** P<0.001 vs. control, ### P<0.001 vs. 
insulin alone). 
3.4 Rosemary extract prevents the palmitate-induced phosphorylation of JNK in L6 
myotubes 
 
Following the establishment that chronic exposure to palmitate increases the 
phosphorylation of Ser307 and Ser636/639 of IRS-1, we examined the signaling 
molecules that may be involved in the process. JNK is a serine/threonine kinase shown to 
increase serine phosphorylation of IRS-1 and involved in insulin resistance (83,87). We 
hypothesized that the levels of JNK phosphorylation and/or expression would be 
increased by palmitate. Indeed, exposure of the cells to palmitate (0.2 mM) significantly 
increased JNK phosphorylation (250±9.77% of control, P<0.001) and prior treatment 
with RE completely abolished the palmitate-induced phosphorylation of JNK 
(114±12.90% of control, P<0.001) (Figure 7). RE alone did not have any impact on the 
phosphorylation of JNK (98±7.44% of control). Moreover, the total levels of JNK were 
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not significantly changed by any treatment: P: 107 ±7.21, RE: 104±7.53 and RE+P: 
105±8.76% of control (Figure 7). 
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Figure 7: Effects of palmitate and RE on JNK expression and phosphorylation. 
Fully differentiated myotubes were treated without (control, C) or with 5 g/ml RE 
followed by treatment without or with 0.2 mM of palmitate (P) for 16 hours. After 
exposure to treatment, the cells were lysed and SDS-PAGE was performed, followed by 
immunoblotting with specific antibodies that recognize phosphorylated Thr183/Tyr185 or 
total JNK. A representative immunoblot is shown. The densitometry of the bands, 
expressed in arbitrary units, was calculated using image J. The values are the mean ± SE 
of three separate experiments (*** P<0.001 vs. control, ### P<0.001 vs. palmitate alone). 
3.5 Rosemary extract prevents the palmitate-induced phosphorylation of mTOR in 
L6 myotubes 
 
Another kinase implicated in serine phosphorylation of IRS-1 is mTOR. 
Therefore, we examined the effects of palmitate on mTOR Exposure to palmitate 0.2 mM 
significantly increased mTOR phosphorylation (403±85.60% of control, P< 0.001) 
(Figure 8). RE completely abolished the palmitate-induced phosphorylation of mTOR 
(60±20.53% of control, P<0.001). RE alone did not have any impact on the 
phosphorylation of mTOR (104±13.71% of control). The total levels of mTOR were not 
significantly changed by the treatments: P: 104±3.01, RE: 93±2.44, and RE+P: 
88±3.85% of control (Figure 8). 
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Figure 8: Effects of palmitate and RE on mTOR expression and phosphorylation. Fully 
differentiated myotubes were treated without (control, C) or with 5 g/ml RE for 2 hours 
followed by treatment without or with 0.2 mM of palmitate (P) for 16 hours. After 
exposure to treatment, the cells were lysed and SDS-PAGE was performed, followed by 
immunoblotting with specific antibodies that recognize phosphorylated Ser2448 or total 
mTOR. A representative immunoblot is shown. The densitometry of the bands, expressed 
in arbitrary units, was calculated using image J. The values are the mean ± SE of three 
separate experiments (*** P<0.001 vs. control, ### P<0.001 vs. palmitate alone). 
3.6 Rosemary extract prevents the palmitate-induced phosphorylation of p70 S6K in 
L6 myotubes 
 
We further investigated the effect of palmitate on p70 6SK phosphorylation and 
expression a downstream effector of mTOR, implicated in serine phosphorylation of IRS-
1 and insulin resistance. Myotubes exposed to 0.2 mM palmitate significantly increased 
p70 S6K phosphorylation levels (200±42.55% of control, P<0.001) (Figure 9). Treatment 
with RE prevented the palmitate-induced phosphorylation of p70 S6K (90±7.11% of 
control, p<0.001). RE alone did not have any effect on the phosphorylation of p70 6SK 
(82.12±6.04% of control). The total levels of p70 S6K were not affected by any of the 
treatments (P: 105±5.83, RE: 97 ± 2.21, and RE+P: 92.22 ± 4.23% of control (Figure 9). 
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Figure 9: Effects of palmitate and RE on p70 S6K expression and phosphorylation. 
Fully differentiated myotubes were treated without (control, C) or with 5 g/ml RE for 2 
hours followed by treatment without or with 0.2 mM of palmitate (P) for 16 hours. After 
exposure to treatment, the cells were lysed and SDS-PAGE was performed, followed by 
immunoblotting with specific antibodies that recognize phosphorylated Thr389 or total 
p70 S6K. A representative immunoblot is shown. The densitometry of the bands, 
expressed in arbitrary units, was calculated using image J. The values are the mean ± SE 
of three separate experiments (*** P<0.001 vs. control, ### P<0.001 vs. palmitate alone). 
3.7 Rosemary extract stimulates the phosphorylation of AMPK in the presence of 
palmitate 
 
Previous studies by our group showed that rosemary extract and its polyphenols 
CA and RA increase glucose uptake and this effect may be mediated through AMPK 
(160–162). We investigated the chronic effect of RE on the phosphorylation of AMPK. 
Our results indicate that chronic treatment with RE with 5 g/ml significantly increased 
phosphorylation of AMPK (295±26.94% of control, P<0.001) (Figure 10). Most 
importantly, RE increases phosphorylation of AMPK even in the presence of 0.2 mM of 
palmitate (270±22.54% of control, P<0.001). Treatment with palmitate alone did not have 
any have a significant effect on the phosphorylation of AMPK (150±14.32% of control). 
Furthermore, the total levels of AMPK were not affected by any of the treatments (P: 
103±8.63, RE: 99±13.21, and RE+P: 108±9.33% of control) (Figure 10). 
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Figure 10: Effects of palmitate and RE on AMPK expression and phosphorylation. 
Fully differentiated myotubes were treated without (control, C) or with 5 g/ml RE for 2 
hours followed by treatment without or with 0.2 mM of palmitate (P) for 16 hours. After 
exposure to treatment, the cells were lysed and SDS-PAGE was performed, followed by 
immunoblotting with specific antibodies that recognize phosphorylated Thr172 or total 
AMPK. A representative immunoblot is shown. The densitometry of the bands, expressed 
in arbitrary units, was calculated using image J. The values are the mean ± SE of three 
separate experiments (*** P<0.001 vs. control). 
3.8 Carnosic acid, a polyphenol in rosemary extract, restores the insulin-stimulated 
glucose uptake in palmitate treated muscle cells 
 
 The effects of carnosic acid on insulin-stimulated glucose uptake in palmitate 
treated L6 myotubes were examined. Stimulation with insulin (100 nM, 30 min) resulted 
in two-fold increase in [3H]-2-deoxy-D-glucose uptake (203±2.3% of control, P<0.001) 
(Figure 11). Exposure to palmitate (0.2 mM) alone did not affect the basal glucose uptake 
(105±3.0 of control). The acute insulin response was significantly decreased in the 
palmitate-treated cells (118±4.9% of control) (Figure 11). Exposure to carnosic acid (CA) 
(2 M) alone significantly increased glucose uptake (212±21.1% of control, P<0.001). 
Most importantly, the presence of CA significantly restored the insulin-stimulated 
glucose uptake (185±7.8% of control, P<0.001) in palmitate treated cells (Figure 11). 
These data indicate that the negative effects of palmitate were prevented in the presence 
of carnosic acid. 
 




Figure 11: Carnosic acid, a polyphenol in rosemary extract, restores insulin-
stimulated glucose uptake in palmitate treated muscle cells. Fully differentiated 
myotubes were treated without (control, C) or with 2 M CA for 2 hours followed by 
treatment without or with 0.2 mM of palmitate (P) for 16 hours and stimulation without 
or with 100 nM insulin (I) for 30 min. [3H]-2-deoxy-D-glucose uptake measurements 
were performed as indicated in the method section. The results are the mean of 4-7 
independent experiments, each performed in triplicate and expressed as percent of control 
(***P<0.001 vs. control). 
3.9 Rosmarinic acid, a polyphenol found in rosemary extract restores the insulin-
stimulated glucose uptake in palmitate treated muscle cells 
 
The effects of rosmarinic acid on insulin-stimulated glucose uptake in palmitate 
treated L6 myotubes were examined. Stimulation with insulin (100 nM, 30 min) resulted 
in two-fold increase in [3H]-2-deoxy-D-glucose uptake (198±3.0% of control, P<0.001) 
(Figure 12). Exposure to palmitate (0.2 mM) alone did not affect the basal glucose uptake 
(103±2.0 of control). The acute insulin response was significantly decreased in the 
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palmitate-treated cells (116±5.0% of control). Exposure to rosmarinic acid (RA) (5 M) 
alone significantly increased glucose uptake (177±6.8% of control, P<0.001). Most 
importantly, the presence of RA significantly restored the insulin-stimulated glucose 
uptake (181±14.5% of control, P<0.001) in palmitate treated cells (Figure 12). These data 
indicate that the negative effects of palmitate were abolished in the presence of 
rosmarinic acid. 
 
Figure 12: Rosmarinic acid, a polyphenol in rosemary extract, restores insulin-
stimulated glucose uptake in palmitate treated muscle cells. Fully differentiated 
myotubes were treated without (control, C) or with 5 M RA for 2 hours followed by 
treatment without or with 0.2 mM of palmitate (P) for 16 hours and stimulation without 
or with 100 nM insulin (I) for 30 min. [3H]-2-deoxy-D-glucose uptake measurements 
were performed as indicated in the method section. The results are the mean of 4-7 
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independent experiments, each performed in triplicate and expressed as percent of control 
(***P<0.01). 
3.10 Carnosol, a polyphenol found in rosemary extract restores the insulin-
stimulated glucose uptake in palmitate treated muscle cells 
 
The effects of carnosol (COH) on insulin-stimulated glucose uptake in palmitate 
treated L6 myotubes were examined. Stimulation with insulin (100 nM, 30 min) resulted 
in two-fold increase in the [3H]-2-deoxy-D-glucose uptake (202±3.0% of control, 
P<0.001) (Figure 13). Exposure to palmitate (0.2 mM) alone did not affect the basal 
glucose uptake (103±2.0 of control). The acute insulin response was significantly 
decreased in the palmitate-treated cells (117±4.9% of control). Exposure to COH (25 
M) alone significantly increased glucose uptake (209±18.2% of control, P<0.001). Most 
importantly, the presence of COH significantly restored the insulin-stimulated glucose 
uptake (208±23.0% of control, P<0.001) in palmitate treated cells (Figure 13). These data 
indicate that the negative effects of palmitate were abolished in the presence of carnosol. 
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Figure 13: Carnosol, a polyphenol in rosemary extract, restores insulin-stimulated 
glucose uptake in palmitate treated muscle cells. Fully differentiated myotubes were 
treated without (control, C) or with 25 M COH for 2 hours followed by treatment 
without or with 0.2 mM of palmitate (P) for 16 hours and stimulation without or with 100 
nM insulin (I) for 30 min. [3H]-2-deoxy-D-glucose uptake measurements were performed 
as indicated in the method section. The results are the mean of 4-7 independent 
experiments, each performed in triplicate and expressed as percent of control 
(***P<0.001). 
CHAPTER 4: DISCUSSION 
 
4.1 Rosemary extract ameliorates palmitate-induced insulin resistance 
 
Obesity and elevated FFAs are highly correlated with insulin resistance and are 
major risk factors for the development of type 2 diabetes mellitus (51). Therefore, the 
development of therapeutic agents to combat FFA-induced insulin resistance would be 
beneficial. Previous studies have shown that the FFA palmitate induces insulin resistance 
in skeletal muscle cells (52,240,126,127). Exposure of L6 myotubes to 0.2 mM palmitate 
significantly decreased the insulin-stimulated glucose uptake. Similarly, studies have 
shown that exposure of L6 to 0.2 mM for 18 hours decreased the insulin-stimulated 
glucose uptake indicating insulin resistance (52,240). The palmitate concentration used in 
the present study was 0.2 mM and our data are in agreement with other studies where 
similar palmitate concentrations induced insulin resistance (52,126) (Figure 4, 11-13).  
Most importantly, in the presence of rosemary extract (RE), carnosic acid (CA), 
rosmarinic acid (RA) and carnosol (COH) the palmitate-induced insulin resistance was 
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prevented and the insulin-stimulated glucose uptake was restored to levels comparable to 
the response seen with insulin alone (Figure 4, 11-13).  
Considering the fact that 80% of postprandial glucose uptake is attributed to 
skeletal muscle, new, more affordable interventions that may improve glucose transport 
in this tissue is highly desirable. Recent studies have shown that rosemary extract (RE) 
and rosemary extract polyphenols, increase glucose uptake in vitro (160–162,188,199). 
The effect of RE and its polyphenols were previously examined in healthy muscle cells 
(160–162). However, their effect on palmitate-induced insulin resistant L6 muscle cells 
were never investigated. Our study is the first to show that RE and RE polyphenols 
prevented palmitate-induced insulin resistance in L6 muscle cells.  
4.2 Investigating the Mechanism of Action of RE and its Polyphenols in Insulin 
Resistant Myotubes  
 
In the present study we found that exposure of L6 cells to 0.2 mM palmitate for 
16 hours increased Ser307 and Ser636/639 phosphorylation of IRS-1 (Figure 5). These 
data are in agreement with other studies (61,59,55,74,241). Exposure of L6 muscle cells 
to 0.75 mM palmitate for 16 hours resulted in significant increase of Ser307 and 
Ser636/639 phosphorylation on IRS-1 (126). Similarly, exposure of L6 to 0.5 mM 
palmitate for 16 hours significantly increased Ser307 of IRS-1 (241). Exposure of C2C12 
myotubes to 0.75 mM palmitate for 16 hours also increased Ser307 phosphorylation of 
IRS-1 (242). Apart from these in vitro studies, in vivo animal studies have shown 
increased serine phosphorylation of IRS-1 by elevated fatty acids that correlate with 
insulin resistance. Administration of high-fat/high-carbohydrate diet ad libitum in mice 
resulted in increase of Ser307 phosphorylation of IRS-1 in muscle tissue (61). 
Additionally, administration of HFD for 16 weeks in mice resulted in increase in 
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Ser636/639 phosphorylation of IRS-1 in muscle and adipose tissue (74). Similarly, in 
mice fed with high fat diet for 10 weeks the phosphorylation of Ser307 and Ser636/639 
was markedly increased in muscle and adipose tissue (59). These serine residues on 
IRS-1 have been associated with a reduced function of insulin stimulated IRS-1 and 
more specifically by a decreased association between IRS-1 and PI3K, downstream 
activation of the insulin signaling cascade and glucose uptake (55). The serine residues 
are located towards the end of the phosphotyrosine binding domain of IRS-1 and 
moderate the interaction of IRS-1 with the insulin receptor (55,69). The association of 
the insulin receptor and IRS-1 is significantly lowered once IRS-1 becomes 
phosphorylated on its serine residues. Exposure to RE completely restored the insulin-
stimulated glucose uptake in palmitate-induced insulin resistant muscle cells. These 
findings are the first to show that exposure of the cells to RE and its polyphenols are 
associated with a prevention of the palmitate-induced insulin resistance and restoration 
of the insulin response in L6 muscle cells. These data are in agreement with other 
studies where metformin, the first line of treatment for T2DM, decreased the 
palmitate-induced Ser307 phosphorylation of IRS-1 in L6 muscle cells (154). 
Furthermore, our data showed that exposure of the cells to 0.2 mM palmitate 
for 16 hours significantly attenuated the insulin-stimulated phosphorylation of Akt 
(Figure 6). Our data is in agreement with other studies (100,243–247). Exposure of 
3T3-L1 adipocytes to 0.75 mM palmitate for 16 hours significantly attenuated the 
insulin-stimulated phosphorylation of Akt (243). Exposure of L6 myotubes to 0.75 mM 
palmitate resulted in abolishment of insulin-stimulated phosphorylation of Akt (100). 
Similarly, exposure of C2C12 cells to 0.5 mM palmitate for 16 hours resulted in a 
Inhibition of Free fatty acid-Induced Insulin Resistance by Rosemary Extract 
82 
 
significant decrease in insulin-stimulated phosphorylation of Akt (245). The above 
mentioned in vitro studies are also in agreement with in vivo studies. Namely, 
administration of high fat diet in C57BL/6 mice for 8 weeks significantly decreased the 
insulin-stimulated phosphorylation of Akt in liver tissue (246). Similarly, administration 
of high fat diet in mice significantly attenuated the insulin-induced phosphorylation of 
Akt in isolated soleus muscle (247). Exposure of the cells to RE restored the palmitate-
induced attenuation of the insulin response (Figure 6). These findings are the first to 
show that treatment with RE is associated with a complete restoration of the insulin 
action in palmitate-induced insulin resistance L6 muscle cells. These data are in 
agreement with other studies where treatment with metformin abolished the palmitate-
induced attenuation of Akt in L6 muscle cells (244). 
Exposure of L6 muscle cells to 0.2 mM for 16 hours palmitate significantly 
increased the phosphorylation of JNK (Figure 7). Our data is in agreement with the 
previous studies (83,87,248,249,249,250). Treatment of L6 muscle cells with 0.75 mM 
palmitate significantly increased the phosphorylation of JNK (248). Similarly, in C2C12 
muscle cells, treatment with 0.5 mM palmitate for 12, 24 and 36 hours significantly 
increased the phosphorylation of JNK (250). Additionally, in primary human myotubes, 
treatment with 0.4 mM palmitate for 12 hours significantly increased the phosphorylation 
of JNK. Exposure of 3T3-L1 adipocytes to 0.5 mM palmitate for 12 hours significantly 
increased the phosphorylation of JNK (249). In rats fed with high lipid containing 
western diet for 10-30 days the phosphorylation of JNK was significantly increased in 
hepatic, adipose and muscle tissue (83). Additionally, in C57BL/6J mice lipid infusion 
significantly increased the phosphorylation of JNK in muscle tissue (251). Furthermore, 
Inhibition of Free fatty acid-Induced Insulin Resistance by Rosemary Extract 
83 
 
in Swiss mice fed with fat-rich diet for 8 weeks, the phosphorylation of JNK was 
markedly increased (252). On the other hand, in mice that underwent targeted mutation of 
the JNK locus in order to abolish JNK expression, high fat diet-induced insulin resistance 
was completely prevented (87). All these findings are in agreement with our study and 
indicate that JNK phosphorylation by FFA is associated with insulin resistance. More 
importantly, exposure of the cells to RE significantly attenuated the palmitate-induced 
phosphorylation of JNK (Figure 7). These findings are the first to show that exposure 
of the cells to RE are associated with a decrease in the palmitate-induced 
phosphorylation of JNK in L6 muscle cells. Moreover, these data are also in agreement 
with other studies where quercetin, a polyphenol from the flavonoid group, 
significantly attenuated the palmitate-induced phosphorylation of JNK in L6 muscle 
cells and in muscles obtained from an ob/ob mice (248). 
Furthermore, exposure of L6 cells to 0.2mM palmitate significantly increased the 
phosphorylation of mTOR and its downstream effector p70 6SK (Figure 8 and 9). Our 
data is in agreement with previous studies (253–256,249). Exposure of L6 myotubes to 
0.4 mM palmitate for 4 hours increased the phosphorylation of mTOR and its 
downstream effector p70S6K (253). Similarly, exposure of C2C12 myotubes to 0.75 mM 
palmitate for 18 hours significantly increased the phosphorylation of mTOR and p70 S6K 
(254). Exposure of 3T3-L1 adipocytes to 0.5 mM palmitate for 12 hours significantly 
increased the phosphorylation of mTOR and its downstream effector p70 S6K (249). 
Chronic consumption of high fat diet in Sprague-Dawley rats for 8 weeks resulted in a 
significant increase in phosphorylation of mTOR in skeletal muscle (253). Similarly, in 
C57BL/6 mice administration of high fat diet for 8 weeks resulted in a significant 
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increase in mTOR and p70 S6K phosphorylation in skeletal muscle (255). The studies 
above are in agreement with our study indicating increased mTOR and p70 S6K 
phosphorylation by FFA that is associated with insulin resistance. More importantly, 
exposure of the cells to RE significantly attenuated the palmitate-induced 
phosphorylation of mTOR and p70 S6K (Figure 8 and 9). These findings are the first to 
show that RE is associated with a decrease in palmitate-induced phosphorylation of 
mTOR and p70 S6K in L6 muscle cells. Furthermore, these data are in agreement with 
other studies where treatment with metformin reversed the palmitate-induced increase in 
mTOR and p70 S6K in C2C12 muscle cells (256). 
Furthermore, we investigated the total and phosphorylated levels of AMPK. 
Previously, we found that treatment of L6 myotubes with RE, CA and RA significantly 
increased the phosphorylation of AMPK (160–162). In the present study, we found that 
0.2 mM palmitate for 16 hours did not significantly increase the levels of AMPK (Figure 
10). These findings are in agreement with previous studies (256,257). Therefore, we 
proceeded to examine the effects of RE in the presence of palmitate in muscle cells. 
Exposure of the cells to RE significantly increased the phosphorylation of AMPK even in 
the presence of palmitate (Figure 10). These effects of RE are similar to the effects of 
metformin. Metformin significantly increased the phosphorylation of AMPK in the 
presence of palmitate in C2C12 and L6 muscle cells (244,256). Another study in L6 
found that metformin ameliorates palmitate-induced insulin resistance through AMPK 
activation and suppression of sterol regulatory element-binding protein-1c (SREBP-1c), a 
transcription factor involved in fatty acids synthesis (244). AMPK is a known inhibitor of 
SREBP (258) therefore RE as an activator of AMPK may also supress the promoter 
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activity of SREBP and ameliorate FFA-induced insulin resistance. Furthermore, studies 
have indicated that activation of AMPK significantly lowers the activity of mTOR and its 
downstream effector p70 S6K (259,260). AMPK may directly affect mTOR by 
phosphorylation of the TSC2 and raptor leading to inhibition in its kinase activity 
(110,261). This process is attained by the increase in TSC activity via AMPK 
phosphorylation which in turn drives the intrinsic GTPase activity of Rheb towards the 
GDP-bound form (110,261). Considering that treatment with RE causes phosphorylation 
of AMPK, this may be the mechanism by which RE attenuates the palmitate-induced 
phosphorylation of mTOR and p70 S6K in muscle cells. The AMPK pathway has been 
viewed as an appealing target for the treatment/prevention of insulin resistance and 
T2DM. The role that AMPK plays in mediating the effects of RE and RE polyphenols 
may need further investigations such as using inhibitor of AMPK (Compound C) or 
siRNA techniques. If indeed AMPK plays a major role in the positive effects observed in 
RE and RE polyphenols treated palmitate-induced insulin resistant cells then inhibition of 
AMPK would diminish the effects of the polyphenols, returning the L6 myotubes to their 
initial insulin resistant state. 
It should be noted that exposure to RE alone resulted in 2-fold increase in AMPK 
phosphorylation compared to control. 
Given that AMPK activation can occur by an increase in the AMP: ATP ratio as 
well as activation of its upstream kinases LKB1 and CaMKK it is important to elucidate 
whether these upstream kinases are the mechanisms by which the bioactive compounds 
of RE activate AMPK. Currently, there are no studies that investigated the effects of RE 
and its polyphenols on the mechanism of AMPK activation. RE and RE polyphenols may 
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allosterically moderate the activity of AMPK, increase the activity of its upstream kinases 
including LKB1 and CaMKK (262,263) or lead to an increase in the AMP: ATP ratios as 
a result to inhibition of the mitochondrial complex 1. Studies have demonstrated that 
metformin significantly inhibits the mitochondrial complex 1 (153,157,264) thereby 
activating AMPK. A recent study has indicated that in the absence of fructose 1,6 
biphosphate (FBP), a glycolytic intermediate, the interaction between aldolase and the 
vacuolar-ATPase on the lysosomal surface is altered which leads to creation of AXIN-
based AMPK-activation complex that causes activation of AMPK (265). If the process of 
glycolysis is inhibited by RE, the production of FBP will be decreased which would lead 
to activation of AMPK. On the other hand, if RE indeed inhibits glycolysis and possibly 
acting as a calorie restrictor thereby increasing the AMP: ATP ratios the levels of 
phosphorylated AMPK will also be increased. 
To our surprise, exposure of the cells to RE and palmitate did not have a 
significant effect on the glucose uptake indicating that in the presence of palmitate not 
only the acute insulin response was abolished but also the effect of RE is attenuated 
(Figure 4). It should be noted that RE in the presence of palmitate, resulted in a 
significant increase in AMPK phosphorylation and our data indicate that this increase 
was enough to abolish palmitate-induced phosphorylation of mTOR and p70 S6K leading 
to decrease in serine phosphorylation of IRS-1 but not sufficient to increase the glucose 
uptake in the cells (Figure 10, RE+P increased AMPK phosphorylation, Figure 4: RE+P 
no significant increase in glucose uptake). We have investigated previously the effects of 
RE, CA and RA on glucose transporters in GLUT4 and GLUT1 overexpressing cells and 
found no effect on glucose transporter translocation (160–162) and we had proposed that 
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RE, RA and CA may increase glucose uptake by affecting GLUT3 translocation or by 
affecting glucose transporter activity. The lack of a significant increase in glucose uptake 
by RE in the presence of palmitate (Figure 4: RE+P) indicates that palmitate may affect a 
signaling step downstream of AMPK such as TBC1D1 that prevents the increase in 
glucose transporter activity/glucose uptake. 
A limited number of studies have also examined the antidiabetic effects of RE 
and its polyphenols in vivo. In high fat diet-induced diabetic mice, administration of 
RE significantly decreased the fasting plasma glucose levels (72%), decreased total 
cholesterol (68%), total fat fecal excretion (1-2 fold) and body weight thereby 
improving the lipid profile of the mice (230). Another study found that RE enriched 
with CA significantly ameliorated the high fat diet induced obesity and metabolic 
syndrome in mice (266). Administration of RE enriched with CA in obese rats resulted 
in significant attenuation of TNF and interleukin 1 indicating anti-inflammatory 
effects of RE (267). Moreover, several other studies showed that dietary 
supplementation of RE enriched with CA resulted in body weight and epidydimal fat 
reduction (214), as well as suppression of hepatic steatosis (268). Additionally, in high 
fat diet-induced diabetic rats administration of RA dose-dependently ameliorated 
hyperglycemia and insulin resistance in addition to increasing GLUT4 translocation to 
the plasma membrane in muscle (227). Moreover, a recent study conducted in humans 
that were administered dried rosemary leaves powder have shown significant 
improvement in the blood lipid profile, antioxidant levels and decrease in fasting plasma 
glucose levels (221). These studies demonstrate that RE and its polyphenols exhibit 
antihyperglycemic and antidiabetic properties in vivo and are in agreement with our 
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findings. However, there are currently no studies that elucidate the mechanism involved 
in the effects of RE and its polyphenols. The present study is the first to show 
increased serine phosphorylation of IRS-1, and increased phosphorylation of mTOR, 
p70S6K and JNK by palmitate and an effect of RE treatment to inhibit them and restore 
insulin-stimulated Akt phosphorylation and insulin stimulated glucose uptake. 
It is already established that high oxidative stress is associated with the 
development of diabetes (269). Numerous physiological and biochemical processes in the 
human body produce reactive oxygen species (ROS) such as superoxide, and hydrogen 
peroxide as byproducts. Overproduction of such free radicals causes oxidative damage to 
biomolecules (membrane lipids, nucleic acids, and proteins) resulting in cellular damage 
and leading to many chronic diseases including diabetes (269) while the intake of natural 
antioxidants has been associated with reduced disease risk radical scavenging molecules, 
such as phenolic compounds, nitrogen compounds, vitamins, terpenoids, and some other 
endogenous metabolites, that have been found to be rich in antioxidant activity (183,269). 
Palmitate is a widely known inducer of ROS generation in different tissues including 
muscle (270). Exposure to 0.75 mM palmitate for 24 hours palmitate significantly 
increased the production of ROS in L6 muscle cells (271). Treatment with 0.4 palmitate 
for 6 hours significantly increased the production of ROS in rat’s hepatocytes. In primary 
human hepatocytes exposure to 0.4 mM palmitate for 12 hours also increased the 
production of ROS (272). The findings above are also in agreement with in vivo where 
administration of high fat diet in Wistar rats for 8 weeks significantly increased the ROS 
production (273). Many studies have shown that RE and RE polyphenols attenuate the 
production of ROS and decrease oxidative stress by exhibiting strong antioxidant 
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activities in vitro and in vivo in liver, adipose and skeletal muscle (228,192,205). 
Considering that oxidative stress and the production of ROS is highly linked to insulin 
resistance and T2DM (274), RE may indirectly affect glucose uptake by attenuating the 
oxidative stress and signaling pathways that may negatively impact the glucose uptake 
and induce pathological states such as insulin resistance and T2DM. Additionally, 
oxidative stress and production of ROS can significantly increase the phosphorylation of 
JNK(275–278). Given that RE and its polyphenols exhibit strong antioxidant properties 
(228,192,205) that can delay or prevent the oxidation of different substrates, it may 
prevent the phosphorylation of JNK that is induced by exposure of the cells to palmitate, 
a known generator of ROS. Therefore, the antioxidant effects of RE may be the 
mechanism by which RE attenuates the palmitate-induced phosphorylation of JNK.  
Based on the current evidence from in vivo studies the RE dosage used in vivo 
ranges from 50-200 mg/kg b.w however, how this translates to human is not addressed, 
especially the issue of bioavailability, metabolites and absorption. On that note, only 
limited number of studies investigated the bioavailability of CA and RA in vivo. This 
information is relevant to our study since RE and its polyphenols show significant 
bioavailability in vivo that can also be detected in different tissues. Oral administration of 
RE enriched with CA 80-120 mg (29-49 mg CA) in rats resulted in presence of bioactive 
concentrations of CA and carnosol in plasma (2-30 M) and tissues such as the liver (1-
15 g/g) and small and large intestines (up to several hundred g/g) (279). Intragastric 
administration of 90 mg/kg of CA in rats resulted in slow absorption with maximum time 
of absorption (Tmax) of 125.6 min and bioavailability of 65% with maximum plasma 
concentration (Cmax) of 42 mg/L (220). Moreover, CA had shorter half-life with 
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intravenous administration (68 min) in comparison to intragastric administration (961 
min) (220). Another study found that intragastric administration of 65 mg/kg CA in rats 
had bioavailability of 40%, Tmax of 137 min and Cmax of 35 mg/L (280). Additionally, 
CA was mostly found in a free form in plasma and undergoes fecal excretion rather than 
urinary in animals (280). As per the European Food Safety Authority (EFSA) regulations, 
the predicted maximal exposure to CA (used as a food additive) is a roughly 0.2 mg/kg 
b.w/day (281). Considering the average body weight, 65 % bioavailability and total 
plasma volume the plasma Cmax of CA is calculated to be approximately 3 nM (282). 
Thus, the doses reported by Vaquero et al. in rats which is the equivalent to human doses 
of 50-100 mg of RE or 20-40 mg of CA/kg b.w/day may only be achieved through 
additional consumption of supplements that are enriched with these compounds (220). 
These values are within the range of the limits specified by the EFSA considering that no 
adverse effects were observed in rats that were fed for 90 days (281).  
Oral administration of 50 mg/kg b.w of RA in rats reaches maximum plasma 
concentration of 4.63 M after 30 min and may be found free, conjugated or in 
methylated form of RA (283). The RA metabolites include ferulic, caffeic and m-
coumaric acid and it is typically excreted through the urinary tract (283). Another study 
showed that the Cmax of RA in plasma reached 1.36 M (0.5 mg/L) after 10 min in rats 
that were administered 0.1 mmol/kg (36 mg/kg/b.w) (284). Another study conducted in 
healthy men being administered a single intake of perilla extract that contained 200 mg of 
RA showed Cmax of 0.87-1.43 µM 30 min post-intake (283). However, the relative 
potency of the RA metabolites have not been investigated and remain to be determined. 
Overall the above mentioned studies indicate that administration of RE or RE 
Inhibition of Free fatty acid-Induced Insulin Resistance by Rosemary Extract 
91 
 
polyphenols in vivo results in detectable polyphenol levels in plasma (1-105 M 
(285,286) range in some studies) and tissues and strongly suggest that our in vitro 
findings have in vivo relevance.  
The exact mechanism by which CA and RA or other RE polyphenols enter the 
cells is not yet established or directly examined. Nevertheless, assumptions can be made 
considering the chemical properties of these polyphenols. CA is a lipid-soluble molecule 
(169) and it is possible that CA can penetrate through the cell membrane through simple 
diffusion and therefore accumulate in the cytosol. On the other hand, RA is a water-
soluble molecule thus it may require a protein channel or a protein carrier in order to 
enter the cell (287). Studies have indicated that RA is not affected by the enzymes 
secreted in the digestive system including lipase and amylase nor it is hydrolyzed in the 
intestines. However, it can be degraded into metabolites by the gut microflora before 
absorption such as hydroxylated phenylphropionic and m-coumeric acid (238,284). The 
metabolic derivatives of RA were shown to be absorbed and transported through the 
tissues by the monocarboxylic acid transporter (MCT) (238,284). Moreover, in human 
intestinal Caco-2 cells RA via paracellular diffusion (284). Additionally, previous data 
indicates that RE and its polyphenols have low toxicity and noteworthy bioavailability 




The prevalence of T2DM is constantly increasing and according to the 
International Diabetes association it is expected to affect 420 million people worldwide 
by the year 2040. Additionally, insulin resistance and T2DM are highly correlated with 
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the development of other pathological states including metabolic syndrome, 
cardiovascular diseases and cancer (185). As a result, new treatment strategies to aid in 
the prevention and management of T2DM may be beneficial for our society. As 
previously indicated, increased levels of FFA and obesity are reported to mediate insulin 
resistance in muscle cells (45,118). More recently, RE and its polyphenols have been 
reported to exhibit antidiabetic properties in insulin target tissues in vitro and in vivo. The 
present study has shown that palmitate can induce insulin resistance in L6 rat skeletal 
muscle cells. Exposure of the cells to palmitate significantly decreased the insulin-
stimulated glucose uptake, Akt phosphorylation and increased the phosphorylation of 
Serine307 and Ser636/639 residues on IRS-1. Additionally, palmitate considerably 
increased the phosphorylation of JNK, mTOR and its downstream effector p70 6SK. 
Most importantly RE and RE polyphenols restored insulin-stimulated glucose uptake, 
insulin-stimulated Akt phosphorylation, increased AMPK phosphorylation and abolished 
the palmitate-induced JNK, mTOR and p70 S6K phosphorylation 
4.4 Future Directions and Limitations 
 
Further studies need to be conducted in order to more accurately investigate the 
mechanism of action of RE. With that being said, utilizing siRNA against major signaling 
molecules that are correlated with insulin resistance and were investigated above such as 
AMPK, JNK, mTOR and p70 S6K. It is expected that siRNA against the kinases that are 
associated with insulin resistance would be the same as RE and its polyphenols, to 
ameliorate the negative effects of palmitate in L6 myotubes Additionally, elucidating the 
mechanism by which AMPK is activated by RE and its polyphenols by ATP assays, 
mitochondrial function and biogenesis should further clarify the mechanism by which RE 
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and its polyphenols affect AMPK. The present study exploited a well-established model 
of palmitate-induced insulin resistance in L6 myotubes in vitro (51,100). The 
methodology of this study was focused on investigating the levels of phosphorylation and 
expression of different proteins involved in the insulin signaling including IRS-1, Akt, 
mTOR, p70 S6K, and JNK as well as AMPK. These investigations were conducted using 
immunoblotting. Additionally, the levels of tyrosine phosphorylation/expression of IRS-1 
should be examined. We hypothesize that in the presence of palmitate, the levels of 
tyrosine phosphorylation of IRS-1 is significantly decreased. As mentioned in the 
introduction, PKC and GSK3 have been implicated as strong mediators involved in the 
development of insulin resistance in skeletal muscle cells. The effect of RE and its 
polyphenols on PKC and GSK3 could also be examined. Additionally, the IKK/NFkB 
and immune response pathway has been markedly implicated in FFA-induced insulin 
resistance (288,289). RE and its polyphenols may have the ability to attenuate IKK/NFkB 
activity therefore future research could examine the effects of these polyphenols on the 
IKK/NFkB signaling pathway. Furthermore, in vivo studies need to be conducted in the 
future. For this purpose rat/mouse animal model of obesity such as HFD-induced insulin 
resistance model may be used in order to further examine the physiological effects and 
the mechanism of action of RE and its polyphenols. In addition, primary tissue culture of 
hepatic, adipose and muscle tissue could be extracted from these in vivo models in order 
to add further understanding to this particular research. 
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Buffers and Solutions:  
A list for the preparation of each buffer and solution used to perform the experiments in 
the methods and results section will be presented below.  
Glucose Uptake Assay: HBS Washing Buffer: 140mM NaCI, 5mM KCI, 20mM 
HEPES, 2.5mM MgSO4, 1mM CaCl2, dilute with DD water and fill to 800mL, adjust pH 
to 7.4 and then fill to l L. Total Radioactive Buffer: HBS buffer, dilute 1:1000 hot 2-[3H] 
deoxy-D-glucose, and 1:1000 cold 2-[3H] deoxy-D-glucose in HBS.  
Non-specific radioactive buffer: Use total radioactive buffer, add 1:1000 cytochalasin 
B. 0.9% NaC1: Add 0.9g NaCI per 100ml DD water. 0.05N NaOH: Add 1ml 5N NaOH 
to 99ml DD water.  
Fatty Acid (FA) Palmitate Solutions: Palmitic acid (41mg) was dissolved in bubbling 
O.IN NaOH (1.6mL) and diluted in prewarmed (45-50°C) 9.7% (WN) BSA solution 
(18.4mL).  
Cell Lysis:  
PBS Washing Buffer: 137mM NaCI, 2.7mM KCI, l.5mM KH2PO4, 8.lmM Na2HPO4, 
0.68mM CaCl2, 0.49mM MgCl2, add water to lL and adjust pH to 7.4. SDS Sample 
Buffer: 62.5mM Tris-HCI (PH 6.8), 2% w/v SDS, 10% glycerol, 0.01 % bromophenol 
blue, add 0.05% p-mercaptoethanol before use.  
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Cell Lysis Buffer: 20mM Tris (PH 7.5), lS0mMNaCI, 1mM EDTA, 1mM EGTA, 1% 
Triton X-100, 2.5mM sodium pyrophosphate, 1mM p-glycerolphosphate, 1mM Na3VO4, 
1 J.lg/mlleupeptin, add 1 mM PMSF before use and chill on ice.  
Western Blotting:  
l.5M Tris-HCI (pH 8.8): 27.23g Tris base (18.15g/100ml), 80ml deionized water, adjust 
to pH 8.8 with 6N HCL. Bring to total volume 150ml with deionized water.  
0.5M Tris-HCI (PH 6.8): 6g Tris base, 60ml deionized water, adjust to pH 6.8 with 6N 
HCI and bring total volume to 100ml with deionized water.  
Resolving Gel Buffer: 12.3 ml DD water, 9.9 ml 30% Acrylamide/ Bis solution, 7.5ml 
1.5M Tris- Hcl, pH 8.8, 0.3ml 10% w/v SDS. Right before pouring the gel, add 150l 
10% APS (0.01g/ 100 l) made fresh daily and l5 l TEMED and swirl.  
Stacking Gel Buffer: l8.3 ml DD water, 3.9 ml 30% Acrylamide/ Bis solution, 7.5ml 
0.5M Tris-HCI, pH 6.8, 0.3 ml 10% w/v SDS. Right before pouring the gel, add l50l % 
APS (0.01g/ 100 l) made fresh daily and 30 l TEMED and swirl.  
10x TBS (Tris- buffered saline): 24.2g Tris base, 80g NaCI, adjust pH to 7.6 with HCl. 
Use at 1x TBS. Dissolve in l L of water.  
Blocking Buffer: 1x TBS, 0.1 % tween 20, 5% w/v non-fat dry milk. Dissolved in water. 
Primary Antibody Dilution Buffer: 2ml 10x TBS, 18ml water, 1.0g BSA, 20ul Tween- 
20.  
Wash Buffer:TBS/T: 1x TBS and 0.1% Tween- 20.  
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10x Electrode Running Buffer: 15.15g Tris base, 72g Glycine, 5.0g SDS. Dissolve and 
bring volume to 500ml with DD water. Do not adjust pH with acid or base. Dilute 50ml 
of 10x stock with 450ml water before use.  
Transfer Buffer: 25mM Tris base, 0.2M glycine, 20% methanol, dissolved in 800mL of 
water. 
